1
|
Ceccanti C, Davini A, Lo Piccolo E, Lauria G, Rossi V, Ruffini Castiglione M, Spanò C, Bottega S, Guidi L, Landi M. Polyethylene microplastics alter root functionality and affect strawberry plant physiology and fruit quality traits. J Hazard Mater 2024; 470:134164. [PMID: 38583200 DOI: 10.1016/j.jhazmat.2024.134164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 02/24/2024] [Accepted: 03/27/2024] [Indexed: 04/09/2024]
Abstract
Strawberry, a globally popular crop whose fruit are known for their taste and health benefits, were used to evaluate the effects of polyethylene microplastics (PE-MPs) on plant physiology and fruit quality. Plants were grown in 2-L pots with natural soil mixed with PE-MPs at two concentrations (0.2% and 0.02%; w/w) and sizes (⌀ 35 and 125 µm). Plant physiological responses, root histochemical and anatomical analyses as well as fruit biometric and quality features were conducted. Plants subjected to ⌀ 35 µm/0.2% PE-MPs exhibited the most severe effects in terms of CO2 assimilation due to stomatal limitations, along with the highest level of oxidative stress in roots. Though no differences were observed in plant biomass, the impact on fruit quality traits was severe in ⌀ 35 µm/0.2% MPs treatment resulting in a drop in fruit weight (-42%), soluble solid (-10%) and anthocyanin contents (-25%). The smallest sized PE-MPs, adsorbed on the root surface, impaired plant water status by damaging the radical apparatus, which finally resulted in alteration of plant physiology and fruit quality. Further research is required to determine if these alterations also occur with other MPs and to understand more deeply the MPs influence on fruit physio-chemistry.
Collapse
Affiliation(s)
- C Ceccanti
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy
| | - A Davini
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy
| | - E Lo Piccolo
- Department of Agriculture, Food, Environment and Forestry, University of Florence, viale delle Idee 30, 50019 Sesto Fiorentino, Firenze, Italy.
| | - G Lauria
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy
| | - V Rossi
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy
| | - M Ruffini Castiglione
- Department of Biology, University of Pisa, via Luca Ghini, 13, 56126 Pisa, Italy; CIRSEC, Centre for Climate Change Impact, University of Pisa, Pisa, Italy
| | - C Spanò
- Department of Biology, University of Pisa, via Luca Ghini, 13, 56126 Pisa, Italy; CIRSEC, Centre for Climate Change Impact, University of Pisa, Pisa, Italy
| | - S Bottega
- Department of Biology, University of Pisa, via Luca Ghini, 13, 56126 Pisa, Italy
| | - L Guidi
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy; CIRSEC, Centre for Climate Change Impact, University of Pisa, Pisa, Italy
| | - M Landi
- Department of Agriculture, Food and Environment, University of Pisa, via del Borghetto, 80, 56124 Pisa, Italy; CIRSEC, Centre for Climate Change Impact, University of Pisa, Pisa, Italy.
| |
Collapse
|
2
|
Boudriga I, Poindron C, Khammeri Y, Zouari AB, Rossi V, Thyssen M, Desboeufs K, Hassen MB. Corrigendum to "Impact of atmospheric deposition on the dynamics of ultraphytoplanktonic populations in the Gulf of Gabès during an intense dust event (MERITE-HIPPOCAMPE campaign)" [Mar. Pollut. Bull. 200 (2024) 116059]. Mar Pollut Bull 2024; 202:116234. [PMID: 38552534 DOI: 10.1016/j.marpolbul.2024.116234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2024]
Affiliation(s)
- Ismail Boudriga
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia.
| | - Charlotte Poindron
- Université Paris Cité and Univ Paris Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Yosra Khammeri
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Amel Bellaaj Zouari
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Vincent Rossi
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO UM 110, 13288 Marseille, France
| | - Melilotus Thyssen
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO UM 110, 13288 Marseille, France
| | - Karine Desboeufs
- Université Paris Cité and Univ Paris Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Malika Bel Hassen
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| |
Collapse
|
3
|
Peters DR, Bernard J, Morgan R, Rossi V. Posterior Transdural Repair of a Spontaneous Ventral Thoracic Cerebrospinal Fluid Leak: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown) 2024:01787389-990000000-01127. [PMID: 38634675 DOI: 10.1227/ons.0000000000001164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Accepted: 02/19/2024] [Indexed: 04/19/2024] Open
Abstract
Spontaneous intracranial hypotension is a rare but serious condition characterized by orthostatic headaches and a variety of neurological symptoms. 1,2 Spontaneous intracranial hypotension should be considered in all patients with new onset, daily, persistent headaches, and orthostatic symptoms. It is typically caused by spontaneous spinal cerebrospinal fluid (CSF) leaks. 1,2 Traditional first-line treatments include hydration, bedrest, epidural blood patches, and fibrin glue injections. However, refractory cases often require surgical intervention, especially those caused by a small ventral osteophyte, which is classified as a type 1 leak. 3-5 The small osteophyte causes a tear in the dura of the ventral canal, usually near the cervicothoracic junction. Diagnosis of these leaks is challenging because these small osteophytes can also occur asymptomatically, or patients may have several of them at multiple levels. Typically, dynamic myelography is needed for accurate localization due to the inadequacy of standard imaging. 6 This video details a young patient with refractory spontaneous intracranial hypotension from a type 1 spontaneous CSF leak, treated successfully using a posterior transdural surgical approach with spinal cord mobilization. Our video presentation outlines the surgical technique and provides an overview of this underdiagnosed condition. Our described approach offers direct visualization, suturing of the leak site, and a multilayer repair without the need for spinal fusion. It also avoids the morbidity to the neck, chest, and mediastinal structures that is at risk with lateral or anterior approaches. A combined intradural and extradural repair may enhance the durability of repair for ventral CSF leaks. The patient consented to the procedure. This operative video did not require Institutional Review Board approval as all patient information has been anonymized, ensuring no identifiable information is disclosed. The video is a single case that does not involve interventions or pose risks beyond standard care, adhering to ethical guidelines and institutional policies.
Collapse
Affiliation(s)
- David R Peters
- Carolina Neurosurgery and Spine Associates, Charlotte , North Carolina , USA
- Department of Neurosurgery, Atrium Health, Charlotte , North Carolina , USA
| | - Joe Bernard
- Carolina Neurosurgery and Spine Associates, Charlotte , North Carolina , USA
- Department of Neurosurgery, Atrium Health, Charlotte , North Carolina , USA
| | - Robert Morgan
- Charlotte Radiology, Charlotte , North Carolina , USA
| | - Vincent Rossi
- Carolina Neurosurgery and Spine Associates, Charlotte , North Carolina , USA
- Department of Neurosurgery, Atrium Health, Charlotte , North Carolina , USA
| |
Collapse
|
4
|
Boudriga I, Poindron C, Khammeri Y, Zouari AB, Rossi V, Thyssen M, Desboeufs K, Bel Hassen M. Impact of atmospheric deposition on the dynamics of ultraphytoplanktonic populations in the Gulf of Gabès during an intense dust event (MERITE-HIPPOCAMPE campaign). Mar Pollut Bull 2024; 200:116059. [PMID: 38335628 DOI: 10.1016/j.marpolbul.2024.116059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 12/07/2023] [Accepted: 01/17/2024] [Indexed: 02/12/2024]
Abstract
The ultraphytoplankton composition and dynamics were assessed during a Saharan dust event occurring off the southern Tunisian coasts during the MERITE-HIPPOCAMPE Trans-Mediterranean oceanographic cruise. The composition of atmospheric dust was characterized in terms of nutriments and trace metals. Data-assimilative hydrodynamic model revealed no differences in the hydrological features along the sampling track and almost no water transport occurred during the period of atmospheric deposition. Dust deposition increased the growth rates and the productivity of the major phytoplanktonic cytometric groups, resulting in the highest surface biomass along the Mediterranean transect. One group, distinguished by low fluorescence and nanoplanktonic size, reacted to dust deposition within hours, exhibiting the highest growth rate and net productivity. The dust composition showed a substantial enrichment with organic phosphorous representing (56 % of Total phosphorus) and trace metals mainly Fe, Mn and V.
Collapse
Affiliation(s)
- Ismail Boudriga
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia.
| | - Charlotte Poindron
- Université Paris Cité and Univ Paris Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Yosra Khammeri
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Amel Bellaaj Zouari
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Vincent Rossi
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO UM 110, 13288 Marseille, France
| | - Melilotus Thyssen
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO UM 110, 13288 Marseille, France
| | - Karine Desboeufs
- Université Paris Cité and Univ Paris Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Malika Bel Hassen
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| |
Collapse
|
5
|
Gennari A, Brain E, De Censi A, Nanni O, Wuerstlein R, Frassoldati A, Cortes J, Rossi V, Palleschi M, Alberini JL, Matteucci F, Piccardo A, Sacchetti G, Ilhan H, D'Avanzo F, Ruffilli B, Nardin S, Monti M, Puntoni M, Fontana V, Boni L, Harbeck N. Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET. Ann Oncol 2024:S0923-7534(24)00057-7. [PMID: 38423389 DOI: 10.1016/j.annonc.2024.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Revised: 01/15/2024] [Accepted: 02/20/2024] [Indexed: 03/02/2024] Open
Abstract
BACKGROUND 18F-FES PET/CT is considered an accurate diagnostic tool to determine whole-body endocrine responsiveness. In the ET-FES trial, we evaluated 18F-FES PET/CT as a predictive tool in ER+/HER2- metastatic breast cancer (MBC). METHODS Eligible patients underwent a 18F-FES PET/CT at baseline. Patients with SUV≥2 received single agent ET until PD; patients with SUV<2 were randomized to single agent ET (Arm A) or chemotherapy (CT) (Arm B). Primary objective was to compare the activity of first line ET versus CT in patients with 18F-FES SUV <2. RESULTS Overall, 147 patients were enrolled; 117 presented with 18F-FES SUV≥2 and received ET; 30 pts with SUV<2 were randomized to ET or CT. After a median follow up of 62.4 months, 104 patients (73.2%) had disease progression and 53 died (37.3%). Median PFS was 12.4 months (95%CI 3.1-59.6) in patients with SUV <2 randomised to Arm A versus 23.0 months (95%CI 7.7-30.0) in Arm B, (HR = 0.71, 95%CI 0.3 - 1.7); median PFS was 18.0 months (95%CI 11.2-23.1) in patients with SUV≥2 treated with ET. Median OS was 28.2 months (95%CI 14.2-NE) in patients with SUV <2 randomized to ET (Arm A) versus 52.8 months (95%CI 16.2-NE) in Arm B (CT). Median OS was not reached in patients with SUV≥2. 60-month OS rate was 41.6% (95%CI 10.4-71.1%) in Arm A, 42.0% (95%CI 14.0-68.2%) in Arm B and 59.6% (95%CI 48.6-69.0%) in patients with SUV≥2. In patients with SUV≥2, 60-months OS rate was 72.6% if treated with aromatase inhibitors versus 40.6% in case of fulvestrant or tamoxifen (p<0.005). CONCLUSIONS The ET-FES trial demonstrated that ER+/HER2- MBC patients are a heterogeneous population, with different levels of endocrine responsiveness based on 18F-FES CT/PET SUV.
Collapse
Affiliation(s)
- A Gennari
- Department of Traslational Medicine, University of Piemonte Orientale, Novara, Italy;; Division of Medical Oncology, Maggiore University Hospital, Novara, Italy.
| | - E Brain
- Department of Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud, France
| | - A De Censi
- Medical Oncology, E.O. "Ospedali Galliera, Genova, Italy
| | - O Nanni
- Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
| | - R Wuerstlein
- Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany
| | - A Frassoldati
- Clinical Oncology, S. Anna University Hospital, Ferrara, Italy
| | - J Cortes
- International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain
| | - V Rossi
- Division of Medical Oncology, Maggiore University Hospital, Novara, Italy
| | - M Palleschi
- Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
| | - J L Alberini
- Nuclear Medicine Department Centre Georges-Francois Leclerc, Dijon Cedex, France
| | - F Matteucci
- Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST)- Dino Amadori, Meldola, Italy
| | - A Piccardo
- Department of Nuclear Medicine, E.O. "Ospedali Galliera, Genova, Italy
| | - G Sacchetti
- Division of Nuclear Medicine Unit, Maggiore University Hospital, Novara, Italy
| | - H Ilhan
- Department of Nuclear Medicine, LMU University Hospital, Munich, Germany
| | - F D'Avanzo
- Division of Medical Oncology, Maggiore University Hospital, Novara, Italy
| | - B Ruffilli
- Department of Traslational Medicine, University of Piemonte Orientale, Novara, Italy
| | - S Nardin
- Medical Oncology Unit 1, IRCCS - Ospedale Policlinico San Martino, Genoa, Italy
| | - M Monti
- Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
| | - M Puntoni
- Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma, Italy
| | - V Fontana
- Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa 20900, Italy
| | - L Boni
- Department of Clinical Epidemiology, IRCSS Ospedale Policlinico San Martino, Genoa 20900, Italy
| | - N Harbeck
- Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany
| |
Collapse
|
6
|
Rwawi C, Hernández-Carrasco I, Sudre F, Tedetti M, Rossi V. Transport patterns and hydrodynamic context of the MERITE-HIPPOCAMPE cruise: Implications for contaminants distribution and origin. Mar Pollut Bull 2024; 198:115743. [PMID: 38104384 DOI: 10.1016/j.marpolbul.2023.115743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 09/22/2023] [Accepted: 10/31/2023] [Indexed: 12/19/2023]
Abstract
This study aims at characterizing the hydrodynamic context and transport patterns that prevailed during the MERITE-HIPPOCAMPE cruise to assist in the interpretation of in-situ observations. The main physical attributes and structures (mesoscale eddies as well as fine-scale fronts and filaments) are analyzed based on various physical diagnostics. They were computed from satellite data and data-assimilative model outputs to describe ocean dynamics. The Northern and Algerian Currents were prominent features during the cruise while the western basin is divided by the vertically-tilted Balearic front. Temperature and salinity were used to distinguish different water masses at both surface and sub-surface. Sea-level anomalies, relative vorticity, and Okubo-Weiss parameter distributions have shown the presence of marked eddies around stations St10 and St11. Furthermore, Finite-Size Lyaponuv Exponents revealed that the former was rather located on a fine-scale filament near the edge of a cyclonic eddy while the latter was closer to the core of an anticyclone. Nearshore thermal fronts were detected with the Belkin and O'Reilly Algorithm (BOA), especially around stations St17 and St19. The potential coastal sources of contaminants were tested using Lagrangian Origin Maps (LOM), suggesting that stations St1, St2, St4, St11, and St15 were most likely influenced by coastal waters. Additionally, an atmospheric reanalysis combined with a Lagrangian dispersal model allowed for estimating wet deposition events of contaminants while tracking the fate of water masses where rainfall took place. Finally, we provide a set of explanatory quantitative and qualitative variables for future statistical analyses that aim at explaining the distribution of both chemical and biological samples collected during the cruise.
Collapse
Affiliation(s)
- Chaimaa Rwawi
- Aix Marseille Univ, University of Toulon, CNRS, IRD, MIO UM 110, Marseille 13288, France.
| | | | - Floriane Sudre
- Aix Marseille Univ, University of Toulon, CNRS, IRD, MIO UM 110, Marseille 13288, France
| | - Marc Tedetti
- Aix Marseille Univ, University of Toulon, CNRS, IRD, MIO UM 110, Marseille 13288, France
| | - Vincent Rossi
- Aix Marseille Univ, University of Toulon, CNRS, IRD, MIO UM 110, Marseille 13288, France.
| |
Collapse
|
7
|
Calcaterra V, Gazzarri A, De Silvestri A, Madia C, Baldassarre P, Rossi V, Garella V, Zuccotti G. Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome. J Endocrinol Invest 2023; 46:2319-2325. [PMID: 37040064 DOI: 10.1007/s40618-023-02086-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Accepted: 03/30/2023] [Indexed: 04/12/2023]
Abstract
PURPOSE Patients with Down Syndrome (DS) showed multiple comorbidities, including thyroid disorders, obesity, and metabolic derangement. Different thyroid hormone (THs) patterns and sensitivity to thyroid hormone indices (STHI) seem to be associated with metabolic disorders. The study's aim was to evaluate the prevalence of metabolic syndrome (MS) in pediatric patients affected by DS, taking into consideration the relationship between the metabolic parameters, THs and STHI. METHODS We enlisted 50 euthyroid patients with DS (9.03 ± 4.46). Clinical parameters, TSH, FT3, FT4 and the presence of MS were recorded. Indexes of peripheral sensitivity (FT3/FT4 ratio) and central sensitivity (TSH index, TSHI; TSH T4 resistance index, TT4RI; TSH T3 resistance index, TT3RI) were also detected. Thirty healthy subjects were included as a control group. RESULTS MS was detected in 12% of the subjects with DS. FT3, FT4, and TSH levels were higher in DS than in the control group (p < 0.01); higher levels of FT3/FT4 ratio, TSHI and TT3RI and lower TT4RI values (p < 0.01) were also detected. A significant correlation was detected between FT3 and fasting blood glucose (FBG) (R = 0.46), triglyceride (TG) (r = 0.37), total (r = 0.55) and high density lipoprotein-cholesterol (HDL-C) (r = - 0.38), diastolic blood pressure (DBP) (r = - 0.4); FT3/FT4 ratio and waist circumference (WC) (r = 0.36); TSHI and total (r = 0.30) and HDL cholesterol (r = - 0.31); TT4RI and HDL cholesterol (r = - 0.31); TT3RI and total (r = 0.39) and HDL cholesterol (r = - 032). CONCLUSION We confirmed a higher MS prevalence in children with DS compared to the control group. A significant association between THs, STHI, and the glucose and lipid metabolism parameters was detected supporting their role in metabolic alterations related to the DS.
Collapse
Affiliation(s)
- V Calcaterra
- Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100, Pavia, Italy.
- Pediatric Department, "V. Buzzi" Children's Hospital, 20154, Milan, Italy.
| | - A Gazzarri
- Associazione Vivi Down Onlus, 20158, Milan, Italy
| | - A De Silvestri
- Biometry & Clinical Epidemiology, Scientific Direction, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy
| | - C Madia
- Associazione Vivi Down Onlus, 20158, Milan, Italy
| | - P Baldassarre
- Pediatric Department, "V. Buzzi" Children's Hospital, 20154, Milan, Italy
| | - V Rossi
- Pediatric Department, "V. Buzzi" Children's Hospital, 20154, Milan, Italy
| | - V Garella
- Pediatric Department, "V. Buzzi" Children's Hospital, 20154, Milan, Italy
| | - G Zuccotti
- Department of Biomedical and Clinical Science "L. Sacco", University of Milan, 20157, Milan, Italy
| |
Collapse
|
8
|
Sudre F, Hernández-Carrasco I, Mazoyer C, Sudre J, Dewitte B, Garçon V, Rossi V. An ocean front dataset for the Mediterranean sea and southwest Indian ocean. Sci Data 2023; 10:730. [PMID: 37865643 PMCID: PMC10590416 DOI: 10.1038/s41597-023-02615-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Accepted: 10/03/2023] [Indexed: 10/23/2023] Open
Abstract
Fronts are ubiquitous discrete features of the global ocean often associated with enhanced vertical velocities, in turn boosting primary production. Fronts thus form dynamical and ephemeral ecosystems where numerous species meet across all trophic levels. Fronts are also targeted by fisheries. Capturing ocean fronts and studying their long-term variability in relation with climate change is thus key for marine resource management and spatial planning. The Mediterranean Sea and the Southwest Indian Ocean are natural laboratories to study front-marine life interactions due to their energetic flow at sub-to-mesoscales, high biodiversity (including endemic and endangered species) and numerous conservation initiatives. Based on remotely-sensed Sea Surface Temperature and Height, we compute thermal fronts (2003-2020) and attracting Lagrangian coherent structures (1994-2020), in both regions over several decades. We advocate for the combined use of both thermal fronts and attracting Lagrangian coherent structures to study front-marine life interactions. The resulting front dataset differs from other alternatives by its high spatio-temporal resolution, long time coverage, and relevant thresholds defined for ecological provinces.
Collapse
Affiliation(s)
- Floriane Sudre
- Aix Marseille Université, Université de Toulon, CNRS, IRD, MIO, Marseille, France.
| | - Ismael Hernández-Carrasco
- Mediterranean Institute for Advanced Studies (UIB-CSIC), Miquel Marques, 21, Esporles, 07190, Balearic Islands, Spain
| | - Camille Mazoyer
- Aix Marseille Université, Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Joel Sudre
- UAR 2013 CPST, IR DATA TERRA, Z.P. de Brégaillon - CS 20330, 83507, Montpellier, La Seyne Sur Mer, France
| | - Boris Dewitte
- Centro de Estudios Avanzados en Zonas Aridas, Facultad de Ciencias del Mar, Universidad Catolica del Norte, Coquimbo, Chile
- Departamento de Biología Marina, Universidad Católica del Norte, Coquimbo, Chile
- Center for Ecology and Sustainable Management of Oceanic Islands (ESMOI), Faculty of Marine Sciences, Catholic University of the North, Coquimbo, Chile
- UMR5318 Climat, Environnement, Couplages et Incertitudes (CECI), Toulouse, France
| | | | - Vincent Rossi
- Aix Marseille Université, Université de Toulon, CNRS, IRD, MIO, Marseille, France.
| |
Collapse
|
9
|
Monk SH, Zeitouni D, Cowan D, Rossi V, Smith MD, Kim PK, Adamson TE. 367 Microendoscopic Posterior Cervical Foraminotomy in the Ambulatory Setting: A Longitudinal Experience. Neurosurgery 2023. [DOI: 10.1227/neu.0000000000002375_367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/18/2023] Open
|
10
|
Tedetti M, Tronczynski J, Carlotti F, Pagano M, Ismail SB, Sammari C, Hassen MB, Desboeufs K, Poindron C, Chifflet S, Zouari AB, Abdennadher M, Amri S, Bănaru D, Abdallah LB, Bhairy N, Boudriga I, Bourin A, Brach-Papa C, Briant N, Cabrol L, Chevalier C, Chouba L, Coudray S, Yahia MND, de Garidel-Thoron T, Dufour A, Dutay JC, Espinasse B, Fierro-González P, Fornier M, Garcia N, Giner F, Guigue C, Guilloux L, Hamza A, Heimbürger-Boavida LE, Jacquet S, Knoery J, Lajnef R, Belkahia NM, Malengros D, Martinot PL, Bosse A, Mazur JC, Meddeb M, Misson B, Pringault O, Quéméneur M, Radakovitch O, Raimbault P, Ravel C, Rossi V, Rwawi C, Hlaili AS, Tesán-Onrubia JA, Thomas B, Thyssen M, Zaaboub N, Garnier C. Contamination of planktonic food webs in the Mediterranean Sea: Setting the frame for the MERITE-HIPPOCAMPE oceanographic cruise (spring 2019). Mar Pollut Bull 2023; 189:114765. [PMID: 36898272 DOI: 10.1016/j.marpolbul.2023.114765] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Revised: 02/09/2023] [Accepted: 02/19/2023] [Indexed: 06/18/2023]
Abstract
This paper looks at experiential feedback and the technical and scientific challenges tied to the MERITE-HIPPOCAMPE cruise that took place in the Mediterranean Sea in spring 2019. This cruise proposes an innovative approach to investigate the accumulation and transfer of inorganic and organic contaminants within the planktonic food webs. We present detailed information on how the cruise worked, including 1) the cruise track and sampling stations, 2) the overall strategy, based mainly on the collection of plankton, suspended particles and water at the deep chlorophyll maximum, and the separation of these particles and planktonic organisms into various size fractions, as well as the collection of atmospheric deposition, 3) the operations performed and material used at each station, and 4) the sequence of operations and main parameters analysed. The paper also provides the main environmental conditions that were prevailing during the campaign. Lastly, we present the types of articles produced based on work completed by the cruise that are part of this special issue.
Collapse
Affiliation(s)
- Marc Tedetti
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France.
| | - Jacek Tronczynski
- Ifremer, CCEM Contamination Chimique des Ecosystèmes Marins, F-44311 Nantes, France
| | - François Carlotti
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Marc Pagano
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Sana Ben Ismail
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Cherif Sammari
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Malika Bel Hassen
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Karine Desboeufs
- Université Paris Cité et Université Paris-Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Charlotte Poindron
- Université Paris Cité et Université Paris-Est Creteil, CNRS, LISA, F-75013 Paris, France
| | - Sandrine Chifflet
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Amel Bellaaj Zouari
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Moufida Abdennadher
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Sirine Amri
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Daniela Bănaru
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Lotfi Ben Abdallah
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Nagib Bhairy
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Ismail Boudriga
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Aude Bourin
- IMT Nord Europe, Institut Mines-Télécom, Univ. Lille, Centre for Energy and Environment, F-59000 Lille, France
| | - Christophe Brach-Papa
- Ifremer, Unité Littoral, Laboratoire Environnement Ressources Provence Azur Corse, Zone portuaire de Brégaillon, CS 20330, 83507 La Seyne-sur-Mer Cedex, France
| | - Nicolas Briant
- Ifremer, CCEM Contamination Chimique des Ecosystèmes Marins, F-44311 Nantes, France
| | - Léa Cabrol
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Cristele Chevalier
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Lassaad Chouba
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Sylvain Coudray
- Ifremer, Unité Littoral, Laboratoire Environnement Ressources Provence Azur Corse, Zone portuaire de Brégaillon, CS 20330, 83507 La Seyne-sur-Mer Cedex, France
| | - Mohamed Nejib Daly Yahia
- Environmental Sciences Program, Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, PO Box 2713, Doha, Qatar
| | | | - Aurélie Dufour
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Jean-Claude Dutay
- Laboratoire des Sciences du Climat et de l'Environnement LSCE/IPSL, CEA-CNRS-UVSQ, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - Boris Espinasse
- Department of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø, Norway
| | | | - Michel Fornier
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Nicole Garcia
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Franck Giner
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SRTE-LRTA, Cadarache, France
| | - Catherine Guigue
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Loïc Guilloux
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Asma Hamza
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | | | - Stéphanie Jacquet
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Joel Knoery
- Ifremer, CCEM Contamination Chimique des Ecosystèmes Marins, F-44311 Nantes, France
| | - Rim Lajnef
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Nouha Makhlouf Belkahia
- Université de Carthage, Faculté des Sciences de Bizerte, Bizerte, Tunisia; Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire des Sciences de l'Environnement, Biologie et Physiologie des Organismes Aquatiques LR18ES41, Tunis, Tunisia
| | - Deny Malengros
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Pauline L Martinot
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Anthony Bosse
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Jean-Charles Mazur
- Aix Marseille Univ., CNRS, IRD, Collège de France, INRAE, CEREGE, 13545 Aix-en-Provence Cedex 4, France
| | - Marouan Meddeb
- Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire des Sciences de l'Environnement, Biologie et Physiologie des Organismes Aquatiques LR18ES41, Tunis, Tunisia; Université de Carthage, Faculté des Sciences de Bizerte, Laboratoire de Biologie Végétale et Phytoplanctonologie, Bizerte, Tunisia
| | - Benjamin Misson
- Université de Toulon, Aix Marseille Univ., CNRS, IRD, MIO, Toulon, France
| | - Olivier Pringault
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Marianne Quéméneur
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Olivier Radakovitch
- Aix Marseille Univ., CNRS, IRD, Collège de France, INRAE, CEREGE, 13545 Aix-en-Provence Cedex 4, France; Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SRTE-LRTA, Cadarache, France
| | - Patrick Raimbault
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Christophe Ravel
- Ifremer, Unité Littoral, Laboratoire Environnement Ressources Provence Azur Corse, Zone portuaire de Brégaillon, CS 20330, 83507 La Seyne-sur-Mer Cedex, France
| | - Vincent Rossi
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Chaimaa Rwawi
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Asma Sakka Hlaili
- Université de Tunis El Manar, Faculté des Sciences de Tunis, Laboratoire des Sciences de l'Environnement, Biologie et Physiologie des Organismes Aquatiques LR18ES41, Tunis, Tunisia; Université de Carthage, Faculté des Sciences de Bizerte, Laboratoire de Biologie Végétale et Phytoplanctonologie, Bizerte, Tunisia
| | | | - Bastien Thomas
- Ifremer, CCEM Contamination Chimique des Ecosystèmes Marins, F-44311 Nantes, France
| | - Melilotus Thyssen
- Aix Marseille Univ., Université de Toulon, CNRS, IRD, MIO, Marseille, France
| | - Noureddine Zaaboub
- Institut National des Sciences et Technologies de la Mer (INSTM), 28, rue 2 mars 1934, Salammbô 2025, Tunisia
| | - Cédric Garnier
- Université de Toulon, Aix Marseille Univ., CNRS, IRD, MIO, Toulon, France
| |
Collapse
|
11
|
Rossi V, Maalouly J, Choi JYS. Lumbar arthroplasty for treatment of primary or recurrent lumbar disc herniation. Int Orthop 2023; 47:1071-1077. [PMID: 36807736 DOI: 10.1007/s00264-023-05708-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Accepted: 01/24/2023] [Indexed: 02/21/2023]
Abstract
PURPOSE Microdiscectomy is the current gold standard surgical treatment for primary lumbar disc herniations that fail non-surgical measures. Herniated nucleus pulposus is the manifestation of underlying discopathy that remains unaddressed with microdiscectomy. Therefore, risk remains of recurrent disc herniation, progression of the degenerative cascade, and on-going discogenic pain. Lumbar arthroplasty allows for complete discectomy, complete direct and indirect decompression of neural elements, restoration of alignment, restoration of foraminal height, and preservation of motion. In addition, arthroplasty avoids disruption of posterior elements and musculoligamentous stabilizers. The purpose of this study is to describe the feasibility of the use of lumbar arthroplasty in the treatment of patients with primary or recurrent disc herniations. In addition, we describe the clinical and peri-operative outcomes associated with this technique. METHODS All patients that underwent lumbar arthroplasty by a single surgeon at a single institution from 2015 to 2020 were reviewed. All patients with radiculopathy and pre-operative imaging demonstrating disc herniation that received lumbar arthroplasty were included in the study. In general, these patients were those with large disc herniations, advanced degenerative disc disease, and a clinical component of axial back pain. Patient-reported outcomes of VAS back, VAS leg, and ODI pre-operatively, at three months, one year, and at last follow-up were collected. Reoperation rate, patient satisfaction, and return to work were documented at last follow-up. RESULTS Twenty-four patients underwent lumbar arthroplasty during the study period. Twenty-two (91.6%) patients underwent lumbar total disc replacement (LTDR) for a primary disc herniation. Two patients (8.3%) underwent LTDR for a recurrent disc herniation after prior microdiscectomy. The mean age was 40 years. The mean pre-operative VAS leg and back pain were 9.2 and 8.9, respectively. The mean pre-operative ODI was 22.3. Mean VAS back and leg pain was 1.2 and 0.5 at three months post-operative. The mean VAS back and leg pain was 1.3 and 0.6 at one year post-operative. The mean ODI was 3.0 at one year post-operative. One patient (4.2%) underwent re-operation for migrated arthroplasty device which required repositioning. At last follow-up, 92% of patients were satisfied with their outcome and would undergo the same treatment again. The mean time for return-to-work was 4.8 weeks. After returning to work, 89% of patients required no further leave of absence for recurrent back or leg pain at last follow-up. Forty-four percent of patients were pain free at last follow-up. CONCLUSION Most patients with lumbar disc herniations can avoid surgical intervention altogether. Of those that require surgical treatment, microdiscectomy may be appropriate for certain patients with preserved disc height and extruded fragments. In a subset of patients with lumbar disc herniation that require surgical treatment, lumbar total disc replacement is an effective option by performing complete discectomy, restoring disc height, restoring alignment, and preserving motion. The restoration of physiologic alignment and motion may result in durable outcomes for these patients. Longer follow-up and comparative and prospective trials are needed to determine how the outcomes of microdiscectomy may differ from lumbar total disc replacement in the treatment of primary or recurrent disc herniation.
Collapse
Affiliation(s)
- Vincent Rossi
- Spine Ortho Clinic, Victoria, Melbourne, Australia.
- Carolina Neurosurgery and Spine Associates, Charlotte, NC, USA.
- Atrium Health Musculoskeletal Institute, Charlotte, NC, USA.
| | | | | |
Collapse
|
12
|
Martins Pinto Filho M, Paixao GMM, Soares CPM, Gomes PR, Raspail L, Rossi V, Singh K, Perel P, Prabhakaran D, Sliwa-Hahnle K, Ribeiro ALP. ECG abnormalities and their relation to COVID-19 outcomes – a WHF study. Eur Heart J 2022. [PMCID: PMC9619533 DOI: 10.1093/eurheartj/ehac544.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Introduction COVID-19 is a respiratory tract infection caused by the Coronavirus (SARS-CoV-2) and its main clinical manifestations are respiratory. The cardiovascular system can also be affected, especially in patients with severe acute respiratory syndrome [1]. On the other hand, cardiovascular disease (CVD) and risk factors have been shown to be predictors of poor outcomes in COVID-19 [2]. Diverse electrocardiographic abnormalities can be found in this condition [3], although their value as a prognostic predictor have not been properly established due to heterogeneity in abnormalities evaluation and small sample sizes in related studies [4]. Purpose The aim of the present study is to evaluate the association of electrocardiogram (ECG) findings to poor COVID-19 outcomes Methods This is a multicentric cohort study that followed hospitalized adults due to COVID-19, from low-middle and high-income countries as part of the World Heart Federation (WHF) Global Study on CVD and COVID-19 initiative [5]. Participants were followed up from hospital admission until 30 days post discharge. For the present study, participants with a valid ECG were included. ECG findings were described according to standardized measurements [heart rate, PR interval, QRS duration and axis, corrected QT interval (QTc)] and abnormalities (according to the Minnesota code system). Abnormalities utilized were grouped into ischemic abnormalities (q waves and ST-T abnormalities), atrial fibrillation (AF), prolonged QTc, sinus tachycardia (defined for the study as above 120 bpm), right and left bundle branch block and presence of any major abnormality. The primary outcome was defined as death from any cause. The secondary outcomes were intensive care unit (ICU) admission and cardiovascular events (myocarditis, pericarditis, myocardial infarction, acute heart failure, ischemic and hemorrhagic stroke). Multiple logistic regression was used to evaluate the association of ECG abnormalities to the outcomes of interest. Adjustments were made in a step by step fashion including gender, age, country of residence, cardiovascular risk factors (diabetes, hypertension, tobacco use) and presence of comorbidities (CVD, asthma, cancer, immunosuppression and chronic kidney disease). Results The clinical characteristics of the cohort are described in table 1. Figure 1 represents the odds ratio and its 95% confidence interval of having the defined outcomes when presenting a ECG abnormality for the final regression model. Conclusion ECG abnormalities were independently related to poor outcomes in COVID-19 after accounting for multiple confounders. Significant associations were more frequently found for ischemic abnormalities, heart rate above 120 bpm, atrial fibrillation and having at least one major electrocardiographic abnormality. Funding Acknowledgement Type of funding sources: Other. Main funding source(s): Pfizer and Sanofi PasteurWorld Heart Federation
Collapse
Affiliation(s)
| | - G M M Paixao
- Federal University of Minas Gerais , Belo Horizonte , Brazil
| | - C P M Soares
- Federal University of Minas Gerais , Belo Horizonte , Brazil
| | - P R Gomes
- Federal University of Minas Gerais , Belo Horizonte , Brazil
| | - L Raspail
- World Heart Federation , Geneva , Switzerland
| | - V Rossi
- University Heart Center , Zurich , Switzerland
| | - K Singh
- Public Health Foundation of India , Gurugram , India
| | - P Perel
- London School of Hygiene and Tropical Medicine , London , United Kingdom
| | - D Prabhakaran
- Public Health Foundation of India , Gurugram , India
| | | | - A L P Ribeiro
- Federal University of Minas Gerais , Belo Horizonte , Brazil
| |
Collapse
|
13
|
D'Avanzo F, Rossi V, Saggia C, Platini F, Borra G, Martini V, Rua A, Gioffi E, Branni C, Maggiora P, Tassone A, Varughese F, Ram Vachanaram A, Ben Ayed R, Angelillo C, Barcellini A, Boldorini R, Dodaro I, Ferrante D, Gennari A. 159P Peripheral T-lymphocytes senescence and response to neoadjuvant therapy (NAT) in operable breast cancer (BC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
14
|
Gennari A, Brain E, Nanni O, Harbeck N, Cortés J, De Censi A, Piccardo A, Alberini J, Matteucci F, Sacchetti G, Ilhan H, Monti M, Wuerlestein R, Saggia C, Rossi V, D'Avanzo F, Maggiora P, Iacozzi M, Frassoldati A, Boni L. 221P Early prediction of efficacy of endocrine therapy (ET) in metastatic breast cancer (MBC): Pilot study with [18F]fluoro-estradiol-17β (18F-FES) PET/CT. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
15
|
Coric D, Rossi V. Navigated, Percutaneous Posterior Cervical Minimally Invasive Surgery Fixation: Technique and Nuances. Int J Spine Surg 2022; 16:S8-S13. [PMID: 35710726 PMCID: PMC9808793 DOI: 10.14444/8271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Cervical pedicle screw fixation provides a biomechanically superior fixation in comparison to traditional lateral mass screws. The traditional open technique has limited adoption due to technical challenges and significantly increased wound morbidity. Navigated, percutaneous pedicle screw fixation circumvents the traditional technical challenges and minimizes wound morbidity. We present here a technique description and case report of navigated, percutaneous posterior cervical minimally invasive fixation. METHODS Small lateral skin incisions are made on the neck using intraoperative computed tomography-guided navigation. Navigated cervical pedicle screws were placed using the proficient minimally invasive system (Spine Wave, Shelton, CT). RESULTS Minimally invasive cervical fixation options have been limited traditionally. Navigated, percutaneous cervical minimally invasive surgery (MIS) fixation provides an effective, safe option for cervical fixation. This technique is described and illustrated in a case example of a patient who suffered a burst fracture and underwent treatment. CONCLUSIONS Navigated, percutaneous posterior cervical MIS fixation provides biomechanically superior fixation while avoiding the morbidity of traditional, open approaches to the posterior cervical spine. Percutaneous cervical pedicle screw techniques will be pivotal in the continued advancement of posterior cervical decompression and fusion techniques. CLINICAL RELEVANCE Navigated, percutaneous cervical minimally invasive fixation is an achievable form of cervical fixation with acceptable complication rates and radiographic outcomes. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- Domagoj Coric
- Carolina Neurosurgery & Spine Associates, Atrium Health Musculoskeletal Institute, Charlotte, NC, USA
| | - Vincent Rossi
- Carolina Neurosurgery & Spine Associates, Atrium Health Musculoskeletal Institute, Charlotte, NC, USA, Vincent Rossi, Atrium Health Musculoskeletal Institute, Carolina Neurosurgery and Spine Associates, 225 Baldwin Ave, Charlotte, NC 28204, USA;
| |
Collapse
|
16
|
Aurelle D, Thomas S, Albert C, Bally M, Bondeau A, Boudouresque C, Cahill AE, Carlotti F, Chenuil A, Cramer W, Davi H, De Jode A, Ereskovsky A, Farnet A, Fernandez C, Gauquelin T, Mirleau P, Monnet A, Prévosto B, Rossi V, Sartoretto S, Van Wambeke F, Fady B. Biodiversity, climate change, and adaptation in the Mediterranean. Ecosphere 2022. [DOI: 10.1002/ecs2.3915] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Affiliation(s)
- Didier Aurelle
- Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO Marseille France
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
- Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum National d'Histoire Naturelle, CNRS Sorbonne Université, EPHE Paris France
| | - Séverine Thomas
- Aix Marseille Université, Labex‐OT‐Med Aix‐en‐Provence France
| | - Cécile Albert
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | - Marc Bally
- Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO Marseille France
| | - Alberte Bondeau
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | | | | | - François Carlotti
- Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO Marseille France
| | - Anne Chenuil
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | - Wolfgang Cramer
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | - Hendrik Davi
- INRAE, Ecologie des Forêts Méditerranéennes (URFM) Avignon France
| | - Aurélien De Jode
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
- Department of Marine Sciences‐Tjärnö University of Gothenburg, Tjärnö Marine Laboratory Gothenburg Sweden
| | - Alexander Ereskovsky
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
- Saint‐Petersburg State University St. Petersburg Russia
| | - Anne‐Marie Farnet
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | | | - Thierry Gauquelin
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | - Pascal Mirleau
- Aix Marseille Univ, Avignon Université, CNRS, IRD, IMBE Marseille France
| | | | | | - Vincent Rossi
- Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO Marseille France
| | | | - France Van Wambeke
- Aix Marseille Univ, Université de Toulon, CNRS, IRD, MIO Marseille France
| | - Bruno Fady
- INRAE, Ecologie des Forêts Méditerranéennes (URFM) Avignon France
| |
Collapse
|
17
|
Abstract
STUDY DESIGN This is a technique paper describing minimally invasive, navigated, percutaneous pedicle screw fixation of the cervical spine. In addition, we include a retrospective feasibility analysis of our initial experience with 27 patients undergoing this procedure. OBJECTIVE The purpose of this study is to describe the technique of MIS navigated percutaneous cervical pedicle screw instrumentation and to report our initial experience. METHODS This is a retrospective review of 27 patients undergoing MIS navigated percutaneous posterior cervical pedicle screw fixation at 2 institutions. We describe the technique and report the radiographic outcomes and all intraoperative and postoperative complications. RESULTS A total of 27 patients underwent MIS navigated percutaneous pedicle screw fixation. Indications included odontoid fracture, subaxial fracture dislocations and burst fracture, pathological fracture, and degenerative spondylosis. There were no nerve root or vascular injuries. There were no spinal cord injuries. Two screws required repositioning intraoperatively, and 1 patient required reoperation for symptomatic malpositioned screw. CONCLUSIONS MIS navigated percutaneous posterior pedicle screw fixation can be performed safely. These constructs are biomechanically superior with neurovascular complication rates comparable to traditional lateral mass screw technique. While the current indications for this technique are relatively limited, the evolution of MIS cervical decompression techniques as well as navigation and robotics will provide an expanded role for percutaneous cervical pedicle screw instrumentation.
Collapse
Affiliation(s)
| | - Vincent Rossi
- Atrium Health Musculoskeletal Institute, Charlotte, NC, USA
| |
Collapse
|
18
|
Furiosi M, Hasanaliyeva G, Caffi T, Rossi V. Soil covering and biofumigant effect of Armoracia rusticana against spore dispersal and viability of Downy mildew inoculum in viticultural systems-BIOVINE. BIO Web Conf 2022. [DOI: 10.1051/bioconf/20225003004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
19
|
Furiosi M, Rossi V, Legler S, Caffi T. Study on fungicides’ use in viticulture: present and future scenarios to control powdery and downy mildew. BIO Web Conf 2022. [DOI: 10.1051/bioconf/20225003006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Taibi O, Bardelloni V, Bove F, Scaglia F, Caffi T, Rossi V. Activity of resistance inducers against Plasmopara viticola in vineyard. BIO Web Conf 2022. [DOI: 10.1051/bioconf/20225003003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
21
|
Salotti I, Bove F, Rossi V. Field evaluation of grapevines resistant to downy and powdery mildews. BIO Web Conf 2022. [DOI: 10.1051/bioconf/20225002003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
22
|
Taibi O, Furiosi M, Caffi T, Rossi V. Characterization of the Folpet fungicidal activity against Plasmopara viticola. BIO Web Conf 2022. [DOI: 10.1051/bioconf/20225003002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Mulvaney G, Rice OM, Rossi V, Peters D, Smith M, Patt J, Pfortmiller D, Asher AL, Kim P, Bernard J, McGirt M. Mild and Severe Obesity Reduce the Effectiveness of Lumbar Fusions: 1-Year Patient-Reported Outcomes in 8171 Patients. Neurosurgery 2021. [DOI: 10.1093/neuros/nyaa414_s083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Abstract
Three procedures dominate surgical management of degenerative cervical spine disorders: posterior cervical laminoforaminotomy (PCF), cervical total disc replacement (CTDR), and anterior cervical discectomy and fusion (ACDF). Together they provide a 360° approach to degenerative cervical spine disease that help surgeons reach the correct treatment decisions. ACDF, CTDR, and PCF are effective procedures for the treatment of a broad range of degenerative cervical disorders. Minimally invasive technique, outpatient setting, motion preservation, and adjacent segment disease should be taken into consideration in the surgical plan. All well-rounded spine surgeons should be skilled at both anterior and posterior approaches to treat radiculopathy.
Collapse
Affiliation(s)
- Vincent Rossi
- Carolina Neurosurgery and Spine Associates, Atrium Health Musculoskeletal Institute, 225 Baldwin Avenue, Charlotte, NC 28204, USA; Atrium Health Musculoskeletal Institute, 1000 Blythe Boulevard, Charlotte, NC 28203, USA.
| | - Tim Adamson
- Carolina Neurosurgery and Spine Associates, Atrium Health Musculoskeletal Institute, 225 Baldwin Avenue, Charlotte, NC 28204, USA; Atrium Health Musculoskeletal Institute, 1000 Blythe Boulevard, Charlotte, NC 28203, USA
| |
Collapse
|
25
|
van der Fels-Klerx H, Liu C, Focker M, Montero-Castro I, Rossi V, Manstretta V, Magan N, Krska R. Decision support system for integrated management of mycotoxins in feed and food supply chains. WORLD MYCOTOXIN J 2021. [DOI: 10.3920/wmj2020.2603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Mycotoxins present a global food safety threat of our feed and food. Mycotoxins are toxic metabolites of certain fungi in agricultural products that are harmful to animal and human health. The presence of mycotoxins in these products depends on a variety of management and environmental factors in the field, during storage and/or processing of feed and food commodities. To date, information on mycotoxin management is available, but is not easy to access by supply chain actors. This study aimed to design, build and test a Decision Support System (DSS) that can help decision making on mycotoxin management by various actors along the feed and food supply chains. As part of this, available knowledge and data on mycotoxin prevention and control were collected and synthesised into easy to understand guidelines and tools for various groups of end-users. The DSS consists of four different modules: (a) static information module and (b) scenario analysis module, (c) dynamic module for forecasting mycotoxins, and (d) dynamic module for real-time monitoring of moulds/mycotoxins in grain silos. Intended end-users are all end-user groups for modules (a) and (b); growers and collectors for module (c) and; post-harvest storage managers for module (d). The DSS is user-friendly and accessible through PCs, tablets and smartphones (see https://mytoolbox-platform.com/ ). In various phases of the DSS development, the tool has been demonstrated to groups of end-users, and their suggestions have been taken into account, whenever possible. Also, a near final version has been tested with individual farmers on the easiness to use the system. In this way we aimed to maximise the DSS uptake by actors along the chain. Ultimately, this DSS will improve decision making on mycotoxin management; it will assist in reducing mycotoxin contamination in the key crops of Europe, thereby reducing economic losses and improving animal and human health.
Collapse
Affiliation(s)
- H.J. van der Fels-Klerx
- Wageningen Food Safety Research, Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands
- Wageningen University, Business Economics Group, Hollandseweg 1, 6706 KN, Wageningen, the Netherlands
| | - C. Liu
- Wageningen Food Safety Research, Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands
| | - M. Focker
- Wageningen University, Business Economics Group, Hollandseweg 1, 6706 KN, Wageningen, the Netherlands
| | - I. Montero-Castro
- IRIS Technology Solutions S.L., Avda. Carl Friedrich Gauss 11, 08860 Castelldefels, Barcelona, Spain
| | - V. Rossi
- Università Cattolica del Sacro Cuore, via Emilia Parmense 84, 29122 Piacenza, Italy
| | - V. Manstretta
- Horta s.r.l., via Egidio Gorra 55, 29122 Piacenza, Italy
| | - N. Magan
- Applied Mycology Group, Environment and AgriFood Theme, Cranfield University, Cranfield, Beds. MK43 0AL, United Kingdom
| | - R. Krska
- Institute of Bioanalytics and Agro-Metabolomics, Department IFA-Tulln, University of Natural Resources and Life Sciences, Vienna (BOKU), Konrad-Lorenz-Str. 20, 3430 Tulln, Austria
- Institute for Global Food Security, School of Biological Sciences, Queens University Belfast, University Road, Belfast, BT7 1NN, Northern Ireland, United Kingdom
| |
Collapse
|
26
|
Griguolo G, Tosi A, Dieci M, Fineberg S, Ventura A, Bottosso M, Bauchet L, Miglietta F, Jacob J, Rossi V, Rigau V, Jacot W, Conte P, Rosato A, Darlix A, Guarneri V. 281P Prognostic impact of immune interactions in HER2+ and triple-negative breast cancer brain metastases. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
27
|
Ser-Giacomi E, Baudena A, Rossi V, Follows M, Clayton S, Vasile R, López C, Hernández-García E. Lagrangian betweenness as a measure of bottlenecks in dynamical systems with oceanographic examples. Nat Commun 2021; 12:4935. [PMID: 34400636 PMCID: PMC8368092 DOI: 10.1038/s41467-021-25155-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Accepted: 07/22/2021] [Indexed: 11/08/2022] Open
Abstract
The study of connectivity patterns in networks has brought novel insights across diverse fields ranging from neurosciences to epidemic spreading or climate. In this context, betweenness centrality has demonstrated to be a very effective measure to identify nodes that act as focus of congestion, or bottlenecks, in the network. However, there is not a way to define betweenness outside the network framework. By analytically linking dynamical systems and network theory, we provide a trajectory-based formulation of betweenness, called Lagrangian betweenness, as a function of Lyapunov exponents. This extends the concept of betweenness beyond the context of network theory relating hyperbolic points and heteroclinic connections in any dynamical system to the structural bottlenecks of the network associated with it. Using modeled and observational velocity fields, we show that such bottlenecks are present and surprisingly persistent in the oceanic circulation across different spatio-temporal scales and we illustrate the role of these areas in driving fluid transport over vast oceanic regions. Analyzing plankton abundance data from the Kuroshio region of the Pacific Ocean, we find significant spatial correlations between measures of diversity and betweenness, suggesting promise for ecological applications.
Collapse
Affiliation(s)
- Enrico Ser-Giacomi
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
| | - Alberto Baudena
- Sorbonne Université,CNRS, Laboratoire d'Océanographie de Villefranche, UMR 7093 LOV, Villefranche‑sur‑Mer, France, Villefranche-sur-Mer, France
| | - Vincent Rossi
- Mediterranean Institute of Oceanography (UM110, UMR 7294), CNRS, Aix Marseille Univ., Univ. Toulon, IRD, Marseille, France
| | - Mick Follows
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
| | | | - Ruggero Vasile
- UP Transfer GmbH, Potsdam, Germany
- GFZ German Research Centre for Geosciences, Potsdam, Germany
| | - Cristóbal López
- IFISC (CSIC-UIB), Instituto de Física Interdisciplinar y Sistemas Complejos, Palma de Mallorca, Spain
| | - Emilio Hernández-García
- IFISC (CSIC-UIB), Instituto de Física Interdisciplinar y Sistemas Complejos, Palma de Mallorca, Spain
| |
Collapse
|
28
|
Del Castillo LM, Buigues A, Rossi V, Soriano MJ, Martinez J, De Felici M, Lamsira HK, Di Rella F, Klinger FG, Pellicer A, Herraiz S. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model. Hum Reprod 2021; 36:2514-2528. [PMID: 34333622 PMCID: PMC8373474 DOI: 10.1093/humrep/deab165] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 05/07/2021] [Indexed: 12/15/2022] Open
Abstract
STUDY QUESTION Does LH protect mouse oocytes and female fertility from alkylating chemotherapy? SUMMARY ANSWER LH treatment before and during chemotherapy prevents detrimental effects on follicles and reproductive lifespan. WHAT IS KNOWN ALREADY Chemotherapies can damage the ovary, resulting in premature ovarian failure and reduced fertility in cancer survivors. LH was recently suggested to protect prepubertal mouse follicles from chemotoxic effects of cisplatin treatment. STUDY DESIGN, SIZE, DURATION This experimental study investigated LH effects on primordial follicles exposed to chemotherapy. Seven-week-old CD-1 female mice were randomly allocated to four experimental groups: Control (n = 13), chemotherapy (ChT, n = 15), ChT+LH-1x (n = 15), and ChT+LH-5x (n = 8). To induce primary ovarian insufficiency (POI), animals in the ChT and ChT+LH groups were intraperitoneally injected with 120 mg/kg of cyclophosphamide and 12 mg/kg of busulfan, while control mice received vehicle. For LH treatment, the ChT+LH-1x and ChT+LH-5x animals received a 1 or 5 IU LH dose, respectively, before chemotherapy, then a second LH injection administered with chemotherapy 24 h later. Then, two animals/group were euthanized at 12 and 24 h to investigate the early ovarian response to LH, while remaining mice were housed for 30 days to evaluate short- and long-term reproductive outcomes. The effects of LH and chemotherapy on growing-stage follicles were analyzed in a parallel experiment. Seven-week-old NOD-SCID female mice were allocated to control (n = 5), ChT (n = 5), and ChT+LH-1x (n = 6) groups. Animals were treated as described above, but maintained for 7 days before reproductive assessment. PARTICIPANTS/MATERIALS, SETTING, METHODS In the first experiment, follicular damage (phosphorylated H2AX histone (γH2AX) staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay), apoptotic biomarkers (western blot), and DNA repair pathways (western blot and RT-qPCR) were assessed in ovaries collected at 12 and 24 h to determine early ovarian responses to LH. Thirty days after treatments, remaining mice were stimulated (10 IU of pregnant mare serum gonadotropin (PMSG) and 10 IU of hCG) and mated to collect ovaries, oocytes, and embryos. Histological analysis was performed on ovarian samples to investigate follicular populations and stromal status, and meiotic spindle and chromosome alignment was measured in oocytes by confocal microscopy. Long-term effects were monitored by assessing pregnancy rate and litter size during six consecutive breeding attempts. In the second experiment, mice were stimulated and mated 7 days after treatments and ovaries, oocytes, and embryos were collected. Follicular numbers, follicular protection (DNA damage and apoptosis by H2AX staining and TUNEL assay, respectively), and ovarian stroma were assessed. Oocyte quality was determined by confocal analysis. MAIN RESULTS AND THE ROLE OF CHANCE LH treatment was sufficient to preserve ovarian reserve and follicular development, avoid atresia, and restore ovulation and meiotic spindle configuration in mature oocytes exposed at the primordial stage. LH improved the cumulative pregnancy rate and litter size in six consecutive breeding rounds, confirming the potential of LH treatment to preserve fertility. This protective effect appeared to be mediated by an enhanced early DNA repair response, via homologous recombination, and generation of anti-apoptotic signals in the ovary a few hours after injury with chemotherapy. This response ameliorated the chemotherapy-induced increase in DNA-damaged oocytes and apoptotic granulosa cells. LH treatment also protected growing follicles from chemotherapy. LH reversed the chemotherapy-induced depletion of primordial and primary follicular subpopulations, reduced oocyte DNA damage and granulosa cell apoptosis, restored mature oocyte cohort size, and improved meiotic spindle properties. LARGE SCALE DATA N/A. LIMITATIONS, REASONS FOR CAUTION This was a preliminary study performed with mouse ovarian samples. Therefore, preclinical research with human samples is required for validation. WIDER IMPLICATIONS OF THE FINDINGS The current study tested if LH could protect the adult mouse ovarian reserve and reproductive lifespan from alkylating chemotherapy. These findings highlight the therapeutic potential of LH as a complementary non-surgical strategy for preserving fertility in female cancer patients. STUDY FUNDING/COMPETING INTEREST(S) This study was supported by grants from the Regional Valencian Ministry of Education (PROMETEO/2018/137), the Spanish Ministry of Science and Innovation (CP19/00141), and the Spanish Ministry of Education, Culture and Sports (FPU16/05264). The authors declare no conflict of interest.
Collapse
Affiliation(s)
- L M Del Castillo
- IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Valencia, Spain
- Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, University of Valencia, Valencia, Spain
| | - A Buigues
- IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Valencia, Spain
| | - V Rossi
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - M J Soriano
- IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Valencia, Spain
| | - J Martinez
- IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Valencia, Spain
- Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, University of Valencia, Valencia, Spain
| | - M De Felici
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - H K Lamsira
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - F Di Rella
- Clinical and Experimental Senology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy
| | - F G Klinger
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - A Pellicer
- IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Valencia, Spain
- IVI-RMA Rome, Rome, Italy
| | - S Herraiz
- Correspondence address. IVI Foundation—IIS La Fe, Reproductive Medicine Research Group, Av. Fernando Abril Martorell, 106-Torre A-Planta1, 46026 Valencia, Spain. Tel: +34-96-390-33-05; E-mail: https://orcid.org/0000-0003-0703-6922
| |
Collapse
|
29
|
d'Arma A, Rossi V, Pugnetti L, Grosso C, Sinatra M, Dos Santos R, Di Giusto G, Mendozzi L. Managing chronic disease in the COVID-19 pandemic: an e-learning application to promote a healthy lifestyle for persons with multiple sclerosis. PSYCHOL HEALTH MED 2021; 27:428-435. [PMID: 34130565 DOI: 10.1080/13548506.2021.1939072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
E-health applications can support continuing care for persons with chronic diseases such as multiple sclerosis (MS). We have developed a web-based mobile app called VIOLA to be used at home by persons with MS (pwMS) who previously participated in an innovative multidisciplinary rehab program. The purpose of VIOLA is to reinforce what participants have learned about a healthy lifestyle and to keep them motivated to adhere to rehabilitation programs. As the outbreak of the Covid-19 pandemic has severely curtailed pwMS contact with their usual health providers, we quickly updated VIOLA to grant continuity of care to our home-bound patients.By monitoring pwMS subscriptions to individual modules, we found a definite increase after the national lockdown was declared. Subscribers rated the app very positively.Encouraged by the positive feedbacks, we are planning to extend the access to our app also to pwMS with no prior specific learning experience. This would limit the psychophysical consequences of the lockdown. Furthermore, VIOLA could be effective in maintaining a proper lifestyle, contributing to improve the quality of life of pwMS.VIOLA has the potential of increasing the adherence of pwMS to the rehabilitation confirming that digital communication tools are a valuable solution for those home-bound.].
Collapse
Affiliation(s)
- A d'Arma
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - V Rossi
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - L Pugnetti
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - C Grosso
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - M Sinatra
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - R Dos Santos
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| | - G Di Giusto
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy.,Department of Biosciences, Università Degli Studi Di Milano, Milano, Italy
| | - L Mendozzi
- IRCCS Fondazione Don Carlo Gnocchi, Unit of Neuromotor Rehabilitation, Multiple Sclerosis Center, Milan, Italy
| |
Collapse
|
30
|
Sen Gupta A, Stellema A, Pontes GM, Taschetto AS, Vergés A, Rossi V. Future changes to the upper ocean Western Boundary Currents across two generations of climate models. Sci Rep 2021; 11:9538. [PMID: 33953259 PMCID: PMC8099859 DOI: 10.1038/s41598-021-88934-w] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Accepted: 04/19/2021] [Indexed: 11/29/2022] Open
Abstract
Western Boundary Currents (WBCs) are important for the oceanic transport of heat, dissolved gases and nutrients. They can affect regional climate and strongly influence the dispersion and distribution of marine species. Using state-of-the-art climate models from the latest and previous Climate Model Intercomparison Projects, we evaluate upper ocean circulation and examine future projections, focusing on subtropical and low-latitude WBCs. Despite their coarse resolution, climate models successfully reproduce most large-scale circulation features with ensemble mean transports typically within the range of observational uncertainty, although there is often a large spread across the models and some currents are systematically too strong or weak. Despite considerable differences in model structure, resolution and parameterisations, many currents show highly consistent projected changes across the models. For example, the East Australian Current, Brazil Current and Agulhas Current extensions are projected to intensify, while the Gulf Stream, Indonesian Throughflow and Agulhas Current are projected to weaken. Intermodel differences in most future circulation changes can be explained in part by projected changes in the large-scale surface winds. In moving to the latest model generation, despite structural model advancements, we find little systematic improvement in the simulation of ocean transports nor major differences in the projected changes.
Collapse
Affiliation(s)
- Alex Sen Gupta
- Climate Change Research Centre, University of New South Wales, Sydney, Australia. .,Australian Research Council Centre of Excellence for Climate Extremes, University of New South Wales, Sydney, Australia. .,Centre for Marine Science and Innovation, University of New South Wales, Sydney, Australia.
| | - Annette Stellema
- Climate Change Research Centre, University of New South Wales, Sydney, Australia.,Australian Research Council Centre of Excellence for Climate Extremes, University of New South Wales, Sydney, Australia.,Centre for Marine Science and Innovation, University of New South Wales, Sydney, Australia
| | - Gabriel M Pontes
- Institute of Oceanography, University of São Paulo, São Paulo, Brazil
| | - Andréa S Taschetto
- Climate Change Research Centre, University of New South Wales, Sydney, Australia.,Australian Research Council Centre of Excellence for Climate Extremes, University of New South Wales, Sydney, Australia
| | - Adriana Vergés
- Centre for Marine Science and Innovation, University of New South Wales, Sydney, Australia.,Centre for Marine Science & Innovation and Evolution & Ecology Research Centre, School of Biological, Earth and Environmental Sciences, UNSW Australia, Sydney, NSW, Australia
| | - Vincent Rossi
- Mediterranean Institute of Oceanography (UM 110, UMR 7294), CNRS, Aix Marseille Univ., Univ. Toulon, IRD, 13288, Marseille, France
| |
Collapse
|
31
|
Ser-Giacomi E, Legrand T, Hernández-Carrasco I, Rossi V. Explicit and implicit network connectivity: Analytical formulation and application to transport processes. Phys Rev E 2021; 103:042309. [PMID: 34005882 DOI: 10.1103/physreve.103.042309] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 03/18/2021] [Indexed: 11/07/2022]
Abstract
Connectivity is a fundamental structural feature of a network that determines the outcome of any dynamics that happens on top of it. However, an analytical approach to obtain connection probabilities between nodes associated with to paths of different lengths is still missing. Here, we derive exact expressions for random-walk connectivity probabilities across any range of numbers of steps in a generic temporal, directed, and weighted network. This allows characterizing explicit connectivity realized by causal paths as well as implicit connectivity related to motifs of three nodes and two links called here pitchforks. We directly link such probabilities to the processes of tagging and sampling any quantity exchanged across the network, hence providing a natural framework to assess transport dynamics. Finally, we apply our theoretical framework to study ocean transport features in the Mediterranean Sea. We find that relevant transport structures, such as fluid barriers and corridors, can generate contrasting and counterintuitive connectivity patterns bringing novel insights into how ocean currents drive seascape connectivity.
Collapse
Affiliation(s)
- Enrico Ser-Giacomi
- Department of Earth, Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, 54-1514 MIT, Cambridge, Massachusetts 02139, USA
| | - Térence Legrand
- Aix Marseille University, Universite de Toulon, CNRS, IRD, Mediterranean Institute of Oceanography (UMR 7294), Marseille, France
| | | | - Vincent Rossi
- Aix Marseille University, University of Toulon, CNRS, IRD, Mediterranean Institute of Oceanography (UMR 7294), Marseille, France
| |
Collapse
|
32
|
Mulvaney G, Rice OM, Rossi V, Peters D, Smith M, Patt J, Pfortmiller D, Asher AL, Kim P, Bernard J, McGirt M. Mild and Severe Obesity Reduce the Effectiveness of Lumbar Fusions: 1-Year Patient-Reported Outcomes in 8171 Patients. Neurosurgery 2021; 88:285-294. [PMID: 33009575 DOI: 10.1093/neuros/nyaa414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2020] [Accepted: 07/05/2020] [Indexed: 01/04/2023] Open
Abstract
BACKGROUND Elevated body mass index (BMI) is a well-known risk factor for surgical complications in lumbar surgery. However, its effect on surgical effectiveness independent of surgical complications is unclear. OBJECTIVE To determine increasing BMI's effect on functional outcomes following lumbar fusion surgery, independent of surgical complications. METHODS We retrospectively analyzed a prospectively built, patient-reported, quality of life registry representing 75 hospital systems. We evaluated 1- to 3-level elective lumbar fusions. Patients who experienced surgical complications were excluded. A stepwise multivariate regression model assessed factors independently associated with 1-yr Oswestry Disability Index (ODI), preop to 1-yr ODI change, and achievement of minimal clinically important difference (MCID). RESULTS A total of 8171 patients met inclusion criteria: 2435 with class I obesity (BMI 30-35 kg/m2), 1328 with class II (35-40 kg/m2), and 760 with class III (≥40 kg/m2). Increasing BMI was independently associated with worse 12-mo ODI (t = 8.005, P < .001) and decreased likelihood of achieving MCID (odds ratio [OR] = 0.977, P < .001). One year after surgery, mean ODI, ODI change, and percentage achieving MCID worsened with class I, class II, and class III vs nonobese cohorts (P < .001) in stepwise fashion. CONCLUSION Increasing BMI is associated with decreased effectiveness of 1- to 3-level elective lumbar fusion, despite absence of surgical complications. BMI ≥ 30 kg/m2 is, therefore, a risk factor for both surgical complication and reduced benefit from lumbar fusion.
Collapse
Affiliation(s)
- Graham Mulvaney
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Olivia M Rice
- Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Vincent Rossi
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - David Peters
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Mark Smith
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Joshua Patt
- Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Deborah Pfortmiller
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Anthony L Asher
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Paul Kim
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
| | - Joe Bernard
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
| | - Matthew McGirt
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina.,Department of Orthopaedic Surgery, Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| |
Collapse
|
33
|
Rossi V, Wait S, Jernigan S, Van Poppel M, Pfortmiller D, Zeitouni D, Henegar MM. Preoperative Acetazolamide Challenge in Pediatric Chiari I Malformation. Pediatr Neurosurg 2021; 56:328-333. [PMID: 34000724 DOI: 10.1159/000515883] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2020] [Accepted: 03/16/2021] [Indexed: 11/19/2022]
Abstract
PURPOSE In patients who present with headaches and Chiari 1 malformation without cranial nerve or brainstem dysfunction or syrinx formation, the decision to decompress can be difficult to make. We present a case series examining the use of acetazolamide as a diagnostic aid to determine candidacy for decompression. METHODS A single pediatric neurosurgeon's (M.M.H.) experience from 2003 to 2018 was retrospectively reviewed. All cases evaluated in the clinic for CPT code of Chiari 1 malformation were analyzed. Inclusion criteria were patients with diagnosis of Chiari 1 malformation and headache-predominant symptoms who underwent an acetazolamide challenge test. Exclusion criteria included age over 18, syrinx, or significant clinical evidence of brainstem compression or cranial nerve dysfunction. Data were recorded with respect to response to acetazolamide. Surgical outcomes were assessed using the Chicago Chiari Outcome Scale (CCOS) pain category and the improve/same/worse (IWS) scale. Overall satisfaction from surgery was also recorded. RESULTS Forty-five patients met inclusion criteria and underwent acetazolamide challenge. Thirty-three (73.3%) patients showed improvement of their symptoms with acetazolamide challenge (responders). Of the 33 responders, 25 (75.8%) underwent Chiari decompression. The remaining 8 (24.2%) responders experienced persistent improvement of their symptoms after the acetazolamide trial and did not require intervention. Twelve (26.7%) patients did not improve with acetazolamide (nonresponders) of which 11 (91.7% of nonreponders) never required intervention. One nonresponder eventually underwent Chiari decompression due to progressively worsening and debilitating headaches. All twenty-five (100%) responders improved after surgery and 24 (96%) were satisfied with the outcome of surgery. The average responder CCOS pain score was 3.52 out of 4. The nonresponder who did not improve with acetazolamide had persistent severe headaches after decompression. The CCOS pain score for this nonresponder was 2 out of 4. CONCLUSION Pediatric headache-predominant Chiari 1 malformation presents a difficult diagnostic dilemma. The authors describe a trial of acetazolamide as a preoperative diagnostic tool to aid the decision to decompress. Further studies will need to be performed to determine the effectiveness of preoperative acetazolamide in identifying which patients may benefit from surgical decompression.
Collapse
Affiliation(s)
- Vincent Rossi
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, USA.,Atrium Health Levine Children's Hospital, Charlotte, North Carolina, USA
| | - Scott Wait
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, USA.,Atrium Health Levine Children's Hospital, Charlotte, North Carolina, USA
| | - Sarah Jernigan
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, USA.,Atrium Health Levine Children's Hospital, Charlotte, North Carolina, USA
| | - Mark Van Poppel
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, USA.,Atrium Health Levine Children's Hospital, Charlotte, North Carolina, USA
| | | | - Daniel Zeitouni
- UNC School of Medicine, Chapel Hill, Chapel Hill, North Carolina, USA
| | - Martin M Henegar
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, USA.,Atrium Health Levine Children's Hospital, Charlotte, North Carolina, USA
| |
Collapse
|
34
|
McGirt MJ, Rossi V, Peters D, Dyer H, Coric D, Asher AL, Pfortmiller D, Adamson T. Anterior Cervical Discectomy and Fusion in the Outpatient Ambulatory Surgery Setting: Analysis of 2000 Consecutive Cases. Neurosurgery 2020. [DOI: 10.1093/neuros/nyz514_s36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Coric D, Roybal RR, Grubb M, Rossi V, Yu AK, Swink IR, Long J, Cheng BC, Inzana JA. Bidirectional Expandable Technology for Transforaminal or Posterior Lumbar Interbody Fusion: A Retrospective Analysis of Safety and Performance. Int J Spine Surg 2020; 14:S22-S30. [PMID: 33122186 DOI: 10.14444/7123] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
BACKGROUND Expandable devices for transforaminal or posterior lumbar interbody fusion (TLIF and PLIF, respectively) may enable greater restoration of disc height, foraminal height, and stability within the interbody space than static spacers. Medial-lateral expansion may also increase stability and resistance to subsidence. This study evaluates the clinical and radiographic outcomes from early experience with a bidirectional expandable device. METHODS This was a retrospective analysis of a continuous series of patients across 3 sites who had previously undergone TLIF or PLIF surgery with a bidirectional expandable interbody fusion device (FlareHawk, Integrity Implants, Inc) at 1 or 2 contiguous levels between L2 and S1. Outcomes included the Oswestry Disability Index (ODI), a visual analog scale (VAS) for back pain or leg pain, radiographic fusion by 1 year of follow-up, subsidence, device migration, and adverse events (AE). RESULTS There were 58 eligible patients with radiographs for 1-year fusion assessments and 45 patients with ODI, VAS back pain, or VAS leg pain data at baseline and a mean follow-up of 4.5 months. The ODI, VAS back pain, and VAS leg pain scores improved significantly from baseline to final follow-up, with mean improvements of 14.6 ± 19.1, 3.4 ± 2.6, and 3.9 ± 3.4 points (P < .001 for each), respectively. In addition, 58% of patients achieved clinically significant improvements in ODI, 76% in VAS back pain, and 71% in VAS leg pain. By 1 year, 96.6% of patients and 97.4% of levels were considered fused. There were zero cases of device subsidence and 1 case of device migration (1.7%). There were zero device-related AEs, 1 intraoperative dural tear, and 3 subsequent surgical interventions. CONCLUSIONS The fusion rate, improvements in patient-reported outcomes, and the AEs observed are consistent with those of other devices. The bidirectional expansion mechanism may provide other important clinical value, but further studies will be required to elucidate the unique advantages. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- Domagoj Coric
- Carolina Neurosurgery & Spine Associates, Atrium Musculoskeletal Institute, Charlotte, North Carolina
| | | | - Mark Grubb
- Northeast Ohio Spine Center, Akron, Ohio
| | - Vincent Rossi
- Carolina Neurosurgery & Spine Associates, Atrium Musculoskeletal Institute, Charlotte, North Carolina
| | - Alex K Yu
- Neuroscience Institute, Allegheny Health Network, Pittsburgh, Pennsylvania
| | - Isaac R Swink
- Neuroscience Institute, Allegheny Health Network, Pittsburgh, Pennsylvania
| | - Jason Long
- Department of Radiology, Allegheny Health Network, Pittsburgh, Pennsylvania
| | - Boyle C Cheng
- Neuroscience Institute, Allegheny Health Network, Pittsburgh, Pennsylvania
| | | |
Collapse
|
36
|
Zuckerman SL, Devin CJ, Rossi V, Chotai S, Dyer EH, Knightly JJ, Potts EA, Foley KT, Bisson EF, Glassman SD, Mummaneni PV, Bydon M, Asher AL. The Institute for Healthcare Improvement-NeuroPoint Alliance collaboration to decrease length of stay and readmission after lumbar spine fusion: using national registries to design quality improvement protocols. J Neurosurg Spine 2020; 33:812-821. [PMID: 32823267 DOI: 10.3171/2020.5.spine20457] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 05/12/2020] [Indexed: 11/06/2022]
Abstract
OBJECTIVE National databases collect large amounts of clinical information, yet application of these data can be challenging. The authors present the NeuroPoint Alliance and Institute for Healthcare Improvement (NPA-IHI) program as a novel attempt to create a quality improvement (QI) tool informed through registry data to improve the quality of care delivered. Reducing the length of stay (LOS) and readmission after elective lumbar fusion was chosen as the pilot module. METHODS The NPA-IHI program prospectively enrolled patients undergoing elective 1- to 3-level lumbar fusions across 8 institutions. A three-pronged approach was taken that included the following phases: 1) Research Phase, 2) Development Phase, and 3) Implementation Phase. Primary outcomes were LOS and readmission. From January to June 2017, a learning system was created utilizing monthly conference calls, weekly data submission, and continuous refinement of the proposed QI tool. Nonparametric tests were used to assess the impact of the QI intervention. RESULTS The novel QI tool included the following three areas of intervention: 1) preoperative discharge assessment (location, date, and instructions), 2) inpatient changes (LOS rounding checklist, daily huddle, and pain assessments), and 3) postdischarge calls (pain, primary care follow-up, and satisfaction). A total of 209 patients were enrolled, and the most common procedure was a posterior laminectomy/fusion (60.2%). Seven patients (3.3%) were readmitted during the study period. Preoperative discharge planning was completed for 129 patients (61.7%). A shorter median LOS was seen in those with a known preoperative discharge date (67 vs 80 hours, p = 0.018) and clear discharge instructions (71 vs 81 hours, p = 0.030). Patients with a known preoperative discharge plan also reported significantly increased satisfaction (8.0 vs 7.0, p = 0.028), and patients with increased discharge readiness (scale 0-10) also reported higher satisfaction (r = 0.474, p < 0.001). Those receiving postdischarge calls (76%) had a significantly shorter LOS than those without postdischarge calls (75 vs 99 hours, p = 0.020), although no significant relationship was seen between postdischarge calls and readmission (p = 0.342). CONCLUSIONS The NPA-IHI program showed that preoperative discharge planning and postdischarge calls have the potential to reduce LOS and improve satisfaction after elective lumbar fusion. It is our hope that neurosurgical providers can recognize how registries can be used to both develop and implement a QI tool and appreciate the importance of QI implementation as a separate process from data collection/analysis.
Collapse
Affiliation(s)
| | - Clinton J Devin
- 2Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
- 3Steamboat Orthopaedic and Spine Institute, Steamboat Springs, Colorado
| | - Vincent Rossi
- 4Carolina Neurosurgery & Spine Associates, Neuroscience and Musculoskeletal Institutes, Atrium Health Charlotte, North Carolina
| | | | - E Hunter Dyer
- 4Carolina Neurosurgery & Spine Associates, Neuroscience and Musculoskeletal Institutes, Atrium Health Charlotte, North Carolina
| | | | - Eric A Potts
- 6Goodman Campbell Brain and Spine, University of Indiana, Indianapolis, Indiana
| | - Kevin T Foley
- 7Department of Neurosurgery, University of Tennessee, Semmes-Murphey Neurologic and Spine Institute, Memphis, Tennessee
| | - Erica F Bisson
- 8Department of Neurosurgery, University of Utah, Salt Lake City, Utah
| | - Steven D Glassman
- 9Norton Leatherman Spine Center, Norton Healthcare, Louisville, Kentucky
| | - Praveen V Mummaneni
- 10Department of Neurosurgery, University of California, San Francisco, California; and
| | - Mohamad Bydon
- 11Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota
| | - Anthony L Asher
- 4Carolina Neurosurgery & Spine Associates, Neuroscience and Musculoskeletal Institutes, Atrium Health Charlotte, North Carolina
| |
Collapse
|
37
|
Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, Klinger FG. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 2020; 25:673-693. [PMID: 31600388 PMCID: PMC6847836 DOI: 10.1093/humupd/dmz027] [Citation(s) in RCA: 274] [Impact Index Per Article: 68.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 07/18/2019] [Accepted: 07/23/2019] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility since the ovarian follicle reserve is extremely sensitive to the effects of chemotherapy and radiotherapy. While oocyte, embryo and ovarian cortex cryopreservation can help some women with cancer-induced infertility achieve pregnancy, the development of effective methods to protect ovarian function during chemotherapy would be a significant advantage. OBJECTIVE AND RATIONALE This paper critically discusses the different damaging effects of the most common chemotherapeutic compounds on the ovary, in particular, the ovarian follicles and the molecular pathways that lead to that damage. The mechanisms through which fertility-protective agents might prevent chemotherapy drug-induced follicle loss are then reviewed. SEARCH METHODS Articles published in English were searched on PubMed up to March 2019 using the following terms: ovary, fertility preservation, chemotherapy, follicle death, adjuvant therapy, cyclophosphamide, cisplatin, doxorubicin. Inclusion and exclusion criteria were applied to the analysis of the protective agents. OUTCOMES Recent studies reveal how chemotherapeutic drugs can affect the different cellular components of the ovary, causing rapid depletion of the ovarian follicular reserve. The three most commonly used drugs, cyclophosphamide, cisplatin and doxorubicin, cause premature ovarian insufficiency by inducing death and/or accelerated activation of primordial follicles and increased atresia of growing follicles. They also cause an increase in damage to blood vessels and the stromal compartment and increment inflammation. In the past 20 years, many compounds have been investigated as potential protective agents to counteract these adverse effects. The interactions of recently described fertility-protective agents with these damage pathways are discussed. WIDER IMPLICATIONS Understanding the mechanisms underlying the action of chemotherapy compounds on the various components of the ovary is essential for the development of efficient and targeted pharmacological therapies that could protect and prolong female fertility. While there are increasing preclinical investigations of potential fertility preserving adjuvants, there remains a lack of approaches that are being developed and tested clinically.
Collapse
Affiliation(s)
- N Spears
- Biomedical Sciences, University of Edinburgh, Edinburgh UK
| | - F Lopes
- Biomedical Sciences, University of Edinburgh, Edinburgh UK
| | | | - V Rossi
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - M De Felici
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| | - R A Anderson
- MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh UK
| | - F G Klinger
- Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
| |
Collapse
|
38
|
Rossi V, Viozzi E, Tripodi F, Porpora M, Simonelli C, Nimbi F. Endometriosis, sexuality and satisfaction: A pilot study on women with and without infertility. Sexologies 2020. [DOI: 10.1016/j.sexol.2020.01.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
39
|
McGirt MJ, Rossi V, Peters D, Dyer H, Coric D, Asher AL, Pfortmiller D, Adamson T. Anterior Cervical Discectomy and Fusion in the Outpatient Ambulatory Surgery Setting: Analysis of 2000 Consecutive Cases. Neurosurgery 2019; 86:E310-E315. [DOI: 10.1093/neuros/nyz514] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Accepted: 09/13/2019] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
In an effort to improve efficiency of care, ambulatory surgery centers (ASCs) have emerged as lower-cost options. Anterior cervical discectomy and fusion (ACDF) is one of the most prevalent spine surgeries performed and rarely requires overnight stays in the hospital, supporting its migration to the ASC. Recent analyses have called into question the safety of outpatient ACDF, potentially slowing its adoption. ASC-ACDF studies have largely been limited to small series, precluding an accurate assessment of safety.
OBJECTIVE
To analyze 2000 ASC-ACDF cases, describe patient selection and perioperative protocol, and report associated safety profile.
METHODS
A total of 2000 patients who underwent 1 to 3 level ACDF in a single ASC from 2006 to 2018 were included in this retrospective analysis. Patients were observed in a 4-h postanesthesia care unit (PACU) with a multimodal pain management regiment. Data were collected on patient demographics, comorbidities, operative details, and 30- and 90-d morbidity.
RESULTS
Of the 2000 patients, 10 (0.5%) required transfer to an inpatient setting within the 4-h observation. Reasons for transfer included hematoma (2), pain control (2), cerebrospinal fluid leak (1), and medical complications (5). Six patients (0.3%) underwent reoperation within 30 d. All-cause 30-d readmission was 1.9%.
CONCLUSION
An analysis of 2000 ACDF patients in an ASC setting with a standardized perioperative protocol demonstrates that surgical complications occur at a low rate (<1%) and can be appropriately diagnosed and managed in a 4-h PACU. In an effort to decrease healthcare costs, surgeons can safely perform ACDFs in an ASC utilizing patient selection criteria and perioperative management protocols similar to those reported here.
Collapse
Affiliation(s)
- Matthew J McGirt
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Vincent Rossi
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - David Peters
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Hunter Dyer
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Domagoj Coric
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Anthony L Asher
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Deborah Pfortmiller
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| | - Tim Adamson
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina
- Atrium Health Musculoskeletal Institute, Charlotte, North Carolina
| |
Collapse
|
40
|
Rossi V, Asher A, Peters D, Zuckerman SL, Smith M, Henegar M, Dyer H, Coric D, Pfortmiller D, Adamson T, McGirt M. Outpatient anterior cervical discectomy and fusion in the ambulatory surgery center setting: safety assessment for the Medicare population. J Neurosurg Spine 2019; 32:360-365. [PMID: 31731271 DOI: 10.3171/2019.7.spine19480] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Accepted: 07/29/2019] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Several studies have demonstrated that anterior cervical discectomy and fusion (ACDF) surgery in the outpatient versus hospital setting provides improved efficiency, cost-effectiveness, and patient satisfaction without a compromise in safety or outcome. Recent anecdotal reports, however, have questioned whether outpatient ACDF surgery is safe in the > 65-year-old Medicare population. To date, no clinical study has assessed the safety of outpatient ACDF in an ambulatory surgery center (ASC), specifically in a Medicare population. The authors set out to analyze their 3-year experience with Medicare-enrolled patients undergoing ACDF surgery at a single ASC to determine its safety profile, perioperative care protocol, and associated outcomes. METHODS A retrospective analysis of 119 consecutive patients > 65 years (Medicare-eligible) who underwent 1-, 2-, or 3-level ACDF at a single ASC from 2015 to 2018 (since Medicare payment approval) was conducted. All patients were in American Society of Anesthesiologists classes I-III. Postoperatively, patients were observed for a minimum of 4 hours in a recovery setting for the following factors: neck swelling, neurological status, ability to swallow solid food, and urination capacity. All patients received a multimodal pain management regimen prior to discharge home. Data were collected on patient demographics, comorbidities, operative details, and all perioperative and 90-day morbidity. RESULTS Complete data were available for all 119 consecutive Medicare-eligible patients, 97 (81.5%) of whom were actively enrolled in Medicare. One-, 2-, and 3-level ACDFs were performed in 103 (86.6%), 15 (12.6%), and 1 (0.8%) patients, respectively. No patients required return to the operating room for intervention within the 4-hour postanesthesia care unit observation window. No patients required transfer from the ASC to the hospital setting for further observation or intervention. Thirty-day adverse events were reported in 2.4% of cases, all of which resolved by 90 days after surgery. The incidence of 90-day hospital readmission was 1.7% (n = 2), with 1 patient (0.8%) requiring reoperation at the index level for deep infection. All-cause 90-day mortality was 0%. CONCLUSIONS An analysis of consecutive Medicare patients (American Society of Anesthesiologists classes I-III) who underwent mostly 1-level and some 2-level ACDFs in an ASC setting demonstrates that surgical complications occur at a low rate with a safety profile similar to that reported for both inpatient ACDF and patients younger than 65 years. In an effort to reduce cost and improve efficiency of care, surgeons can safely perform ACDF in the Medicare population in an ASC environment utilizing patient selection criteria and perioperative management similar to those reported here.
Collapse
|
41
|
Legrand T, Di Franco A, Ser-Giacomi E, Caló A, Rossi V. A multidisciplinary analytical framework to delineate spawning areas and quantify larval dispersal in coastal fish. Mar Environ Res 2019; 151:104761. [PMID: 31399203 DOI: 10.1016/j.marenvres.2019.104761] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Revised: 06/12/2019] [Accepted: 07/15/2019] [Indexed: 06/10/2023]
Abstract
Assessing larval dispersal is essential to understand the structure and dynamics of marine populations. However, knowledge about early-life dispersal is sparse, and so is our understanding of the spawning process, perhaps the most obscure component of biphasic life cycles. Indeed, poorly known species-specific spawning modality and species-specific early-life traits, as well as the high spatio-temporal variability of the oceanic circulation experienced during larval drift, hamper our ability to appraise the realized connectivity of coastal fishes. Here, we propose an analytical framework which combines Lagrangian modelling, network theory, otolith analyses and biogeographical information to pinpoint and characterize larval sources which are then grouped into discrete spawning areas. Such well-delineated larval sources allow improving the quantitative evaluations of both dispersal scales and connectivity patterns. To illustrate its added value, our approach is applied to two case-studies focusing on Diplodus sargus and Diplodus vulgaris in the Adriatic sea. We evidence robust correlations between otolith geochemistry and modelled spawning areas to assess their relative importance for the larval replenishment of the Apulian coast. Our results show that, contrary to D. sargus, D. vulgaris larvae originate from both eastern and western Adriatic shorelines. Our findings also suggest that dispersal distances and dispersal surfaces scale differently with the pelagic larval duration. Furthermore, 30.8% of D. sargus larvae and 23.6% of D. vulgaris larvae of the Apulian populations originate from Marine protected area (MPA), exemplifying larval export from MPAs to surrounding unprotected areas. This flexible multidisciplinary framework, which can be adjusted to any coastal fish and oceanic system, exploits the explanatory power of a dispersal model, fine-tuned and backed-up by observations, to provide more reliable scientific basis for the management and conservation of marine ecosystems.
Collapse
Affiliation(s)
- T Legrand
- Mediterranean Institute of Oceanography (UM 110, UMR 7294), CNRS, Aix Marseille Univ., Univ. Toulon, IRD, 13288, Marseille, France.
| | - A Di Franco
- Stazione zoologica Anton Dohrn, Dipartimento Ecologia Marina Integrata, Sede Interdipartimentale della Sicilia, Lungomare Cristoforo Colombo (complesso Roosevelt), 90142 Palermo, Italy; Université Côte d'Azur, CNRS, UMR 7035 ECOSEAS, Parc Valrose 28, Avenue Valrose, 06108, Nice, France
| | - E Ser-Giacomi
- Sorbonne Universités (UPMC, Université Paris 06)-CNRS-IRD-MNHN, LOCEAN, 4 Place JUSSIEU, F-75005, PARIS, France
| | - A Caló
- Université Côte d'Azur, CNRS, UMR 7035 ECOSEAS, Parc Valrose 28, Avenue Valrose, 06108, Nice, France; Dipartimento di Scienze della Terra e del Mare (DiSTeM), Università di Palermo, Via Archirafi 20, 90123 Palermo, Italy
| | - V Rossi
- Mediterranean Institute of Oceanography (UM 110, UMR 7294), CNRS, Aix Marseille Univ., Univ. Toulon, IRD, 13288, Marseille, France
| |
Collapse
|
42
|
Briot C, Faure P, Parmentier AL, Nachury M, Trang C, Viennot S, Altwegg R, Bulois P, Thomassin L, Serrero M, Ah-Soune P, Gilletta C, Plastaras L, Simon M, Dray X, Caillo L, Del Tedesco E, Abitbol V, Zallot C, Degand T, Rossi V, Bonnaud G, Colin D, Morel B, Winkfield B, Danset JB, Filippi J, Amiot A, Attar A, Levy J, Peyrin-Biroulet L, Vuitton L. Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study. J Crohns Colitis 2019; 13:1121-1130. [PMID: 30785181 DOI: 10.1093/ecco-jcc/jjz040] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND Standard high-volume polyethylene glycol [PEG] bowel preparations [PEG-4L] are recommended for patients with inflammatory bowel disease [IBD] undergoing colonoscopy. However, low-volume preparations [≤2 L of active volume] are often used in clinical practice. The aim of this study was to evaluate the efficacy, tolerability, and safety of the various bowel preparations for patients with IBD, including low-volume preparations. METHODS We conducted a French prospective multicentre observational study over a period of 1 month. Patients aged 18-75 years with IBD with an indication of colonoscopy independent of the study were enrolled. The choice of the preparation was left to the investigators, as per their usual protocol. The patients' characteristics, disease, and colonoscopy characteristics were recorded, and they were given self-reported questionnaires. RESULTS Twenty-five public and private hospitals enrolled 278 patients. Among them, 46 had a disease flare and 41 had bowel stenoses. Bowel preparations for colonoscopy were as follows: 42% received PEG-2L, 29% received sodium picosulfate [Pico], 15% received PEG-4L, and 14% had other preparations. The preparation did not reach the Boston's score efficacy outcome in the PEG-4L group in 51.2% of the patients [p = 0.0011]. The preparation intake was complete for 59.5% in the PEG-4L group, compared with 82.9% in the PEG-2L group and 93.8% in the Pico group [p < 0.0001]. Tolerability, as assessed by the patients' VAS, was significantly better for both Pico and PEG-2L compared with PEG-4L, and better for Pico compared with PEG-2L [p = 0.008; p = 0.0003]. In multivariate analyses, low-volume preparations were independent factors of efficacy and tolerability. Adverse events occurred in 4.3% of the patients. CONCLUSIONS Preparations with PEG-2L and Pico were equally safe, with better efficacy and tolerability outcomes compared with PEG-4L preparations. The best efficacy/tolerance/safety profile was achieved with the Pico preparation.
Collapse
Affiliation(s)
- C Briot
- Department of Gastroenterology, University Hospital of Besançon, University Bourgogne Franche-Comté, Besançon, France
| | - P Faure
- Department of Gastroenterology, Clinique Pasteur, Toulouse, France
| | - A L Parmentier
- Centre de Méthodologie Clinique, University Hospital of Besançon, Besançon, France
| | - M Nachury
- Gastroenterology Department, University Hospital of Lille, Lille, France
| | - C Trang
- Department of Hepatology and Gastroenterology, University Hospital Hotel Dieu, Nantes, France
| | - S Viennot
- Gastroenterology Department, University Hospital of Caen, Caen, France
| | - R Altwegg
- Department of Hepatology and Gastroenterology, University Hospital of St Eloi, Montpellier, France
| | - P Bulois
- Department of Gastroenterology, Hôpital Privé la Louvière, Ramsay Générale de Santé, Lille, France
| | - L Thomassin
- Department of Gastroenterology, University Hospital Charles Nicolle, Rouen, France
| | - M Serrero
- Department of Gastroenterology, APHM, Hopital Nord, Marseille, France
| | - P Ah-Soune
- Department of Hepatology and Gastroenterology, Toulon - La Seyne-sur-Mer Hospital, Toulon, France
| | - C Gilletta
- Department of Gastroenterology, University Hospital Rangueuil, Toulouse, France
| | - L Plastaras
- Department of Hepato-Gastroenterology, Hospital Pasteur, Colmar, France
| | - M Simon
- Gastroenterology Department, Institut Mutualiste Montsouris, Paris, France
| | - X Dray
- Department of Gastroenterology, Sorbonne University & APHP, Hôpital Saint-Antoine, Paris, France
| | - L Caillo
- Department of Gastroenterology and Hepatology, University Hospital Caremeau, Nimes, France
| | - E Del Tedesco
- Department of Gastroenterology, University Hospital of Saint-Etienne, Saint Priest en Jarez, France
| | - V Abitbol
- Department of Gastroenterology, University Hospital Cochin, Paris, France
| | - C Zallot
- Department of Gastroenterology, Inserm U954, University Hospital of Nancy, Lorraine University, Nancy, France
| | - T Degand
- Department of Gastroenterology, University Hospital Le Bocage, Dijon, France
| | - V Rossi
- Department of Gastroenterology, Hospital Haut Anjou, Château Gontier, France
| | - G Bonnaud
- Clinique Ambroise Paré, Toulouse, France
| | - D Colin
- Department of Gastroenterology, Clinique de la Miotte, Belfort, France
| | - B Morel
- Department of Gastroenterology, Centre Hospitalier de Villefranche-sur-Saône, Gleizé, France
| | - B Winkfield
- Department of Hepatology and Gastroenterology, Hôpital Nord Franche-Comté, Trevenans, France
| | - J B Danset
- Department of HepatoGastroenterology, European Georges-Pompidou Hospital, APHP, Paris, France
| | - J Filippi
- Department of Gastroenterology, University Hospital L'Archet, Nice, France
| | - A Amiot
- Department of Gastroenterology, Henri Mondor Hospital, APHP, Creteil, France
| | - A Attar
- Gastroenterology Department, Beaujon University Hospital, Clichy, France
| | - J Levy
- Department of Gastroenterology, Clinique des Cèdres, Cornebarrieu, France
| | - L Peyrin-Biroulet
- Department of Gastroenterology, Inserm U954, University Hospital of Nancy, Lorraine University, Nancy, France
| | - L Vuitton
- Department of Gastroenterology, University Hospital of Besançon, University Bourgogne Franche-Comté, Besançon, France
| | | |
Collapse
|
43
|
Cicardo G, Ursi P, Rossi V, Ceccarelli G, Di Matteo FM, Panarese A, D'Andrea V. The ERAS Protocol is at the forefront of the peri-operative pathway in colorectal surgery: monocentric clinical study. G Chir 2019; 40:276-289. [PMID: 32011978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
INTRODUCTION Colon cancer is one of the most common neoplastic diseases, with onset in old age; the benefits of the ERAS protocol were evaluated in the peri-operative treatment of patients affected by this neoplasm. METHODS We studied 90 cases of colorectal neoplasia observed at the General Surgery UOC of the San Camillo de Lellis Hospital between September 2014 and April 2016, undergoing laparoscopic surgery and to which the ERAS protocol was applied; key points were the preoperative oral feeding, the epidural anesthesia, the reduced or failed hydro-electrolytic overload, the early mobilization and recovery of the feeding, the non-use of drainage. The most important parameers considered were the reduced duration of the operating hospital stay, the lower occurrence of early and distant complications. RESULTS 85 surgical procedures were performed with laparoscopic technique (94.4%) and 5 with traditional open technique (5.6%). The conversion rate was 5.8% (5/85). 29 surgical procedures of right hemicolectomy (32.2%) and 26 of anterior resection of the rectum (28.9%) were performed; in another 29 patients (32.2%) an intervention with an open traditional technique was performed. A balanced anesthesia was performed in 41 patients (45.6%); epidural anesthesia in 32 cases (35.6%); the Tap Block in 17 subjects (18.9%). The average volume of liquid infusion was 1664cc ± 714; the average post-operative hospital stay of 4.3 ± 0.9 days. CONCLUSIONS The ERAS protocol reduces the duration of the post-operative hospitalization, involves a lower incidence of precocious and remote complications, in particular if associated with a minimally invasive surgical method; it is easily applicable and reproducible in a hospital environment, with a marked reduction in healthcare management costs.
Collapse
|
44
|
Hidalgo M, Rossi V, Monroy P, Ser-Giacomi E, Hernández-García E, Guijarro B, Massutí E, Alemany F, Jadaud A, Perez JL, Reglero P. Accounting for ocean connectivity and hydroclimate in fish recruitment fluctuations within transboundary metapopulations. Ecol Appl 2019; 29:e01913. [PMID: 31144784 DOI: 10.1002/eap.1913] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/09/2018] [Revised: 03/11/2019] [Accepted: 03/19/2019] [Indexed: 06/09/2023]
Abstract
Marine resources stewardships are progressively becoming more receptive to an effective incorporation of both ecosystem and environmental complexities into the analytical frameworks of fisheries assessment. Understanding and predicting marine fish production for spatially and demographically complex populations in changing environmental conditions is however still a difficult task. Indeed, fisheries assessment is mostly based on deterministic models that lack realistic parameterizations of the intricate biological and physical processes shaping recruitment, a cornerstone in population dynamics. We use here a large metapopulation of a harvested fish, the European hake (Merluccius merluccius), managed across transnational boundaries in the northwestern Mediterranean, to model fish recruitment dynamics in terms of physics-dependent drivers related to dispersal and survival. The connectivity among nearby subpopulations is evaluated by simulating multi-annual Lagrangian indices of larval retention, imports, and self-recruitment. Along with a proxy of the regional hydroclimate influencing early life stages survival, we then statistically determine the relative contribution of dispersal and hydroclimate for recruitment across contiguous management units. We show that inter-annual variability of recruitment is well reproduced by hydroclimatic influences and synthetic connectivity estimates. Self-recruitment (i.e., the ratio of retained locally produced larvae to the total number of incoming larvae) is the most powerful metric as it integrates the roles of retained local recruits and immigrants from surrounding subpopulations and is able to capture circulation patterns affecting recruitment at the scale of management units. We also reveal that the climatic impact on recruitment is spatially structured at regional scale due to contrasting biophysical processes not related to dispersal. Self-recruitment calculated for each management unit explains between 19% and 32.9% of the variance of recruitment variability, that is much larger than the one explained by spawning stock biomass alone, supporting an increase of consideration of connectivity processes into stocks assessment. By acknowledging the structural and ecological complexity of marine populations, this study provides the scientific basis to link spatial management and temporal assessment within large marine metapopulations. Our results suggest that fisheries management could be improved by combining information of physical oceanography (from observing systems and operational models), opening new opportunities such as the development of short-term projections and dynamic spatial management.
Collapse
Affiliation(s)
- Manuel Hidalgo
- Instituto Español de Oceanografía, Centre Oceanogràfic de les Balears, Moll de Ponent s/n, Palma, 07015, Spain
- Instituto Español de Oceanografía, Centro Oceanográfico de Málaga, Muelle Pesquero s/n, Fuengirola (Málaga), 29640, Spain
| | - Vincent Rossi
- Institute for Cross-Disciplinary Physics and Complex Systems (IFISC), CSIC-UIB, Palma de Mallorca, 07122, Spain
- Mediterranean Institute of Oceanography (MIO, UM 110, UMR 7294), CNRS, Aix Marseille Univ., Univ. Toulon, IRD, Marseille, 13288, France
| | - Pedro Monroy
- Institute for Cross-Disciplinary Physics and Complex Systems (IFISC), CSIC-UIB, Palma de Mallorca, 07122, Spain
| | - Enrico Ser-Giacomi
- Institute for Cross-Disciplinary Physics and Complex Systems (IFISC), CSIC-UIB, Palma de Mallorca, 07122, Spain
- Institut de Biologie de l'École Normale Supérieure (IBENS), Ecole Normale Supérieure, PSL Research University, CNRS, Inserm, Paris, 75005, France
| | - Emilio Hernández-García
- Institute for Cross-Disciplinary Physics and Complex Systems (IFISC), CSIC-UIB, Palma de Mallorca, 07122, Spain
| | - Beatriz Guijarro
- Instituto Español de Oceanografía, Centre Oceanogràfic de les Balears, Moll de Ponent s/n, Palma, 07015, Spain
| | - Enric Massutí
- Instituto Español de Oceanografía, Centre Oceanogràfic de les Balears, Moll de Ponent s/n, Palma, 07015, Spain
| | - Francisco Alemany
- Instituto Español de Oceanografía, Centre Oceanogràfic de les Balears, Moll de Ponent s/n, Palma, 07015, Spain
| | - Angelique Jadaud
- IFREMER, Institut Français de Recherche pour l'Exploitation de la mer, UMR 212 Ecosystèmes Marins Exploités (EME), Sète, France
| | - José Luis Perez
- Instituto Español de Oceanografía, Centro Oceanográfico de Málaga, Muelle Pesquero s/n, Fuengirola (Málaga), 29640, Spain
| | - Patricia Reglero
- Instituto Español de Oceanografía, Centre Oceanogràfic de les Balears, Moll de Ponent s/n, Palma, 07015, Spain
| |
Collapse
|
45
|
Rossi V, Nimbi F, Aversa F, Tripodi F, Porpora M, Simonelli C. PS-02-005 Endometriosis and sexual functioning: How much do psycho-emotional factors matter? J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
D’Avanzo F, Saggia C, Rossi V, Siffredi G, Barone Adesi F, Gennari A. CDK 4/6 inhibitors plus endocrine therapy in ER positive metastatic breast cancer (MBC): Systematic review and meta-analysis of randomized clinical trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz100.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Rossi V, Giannarelli D, Berchialla P, Montemurro F, Ferretti G, Nistico' C, Vigna L, Cognetti F, Fabi A. Abstract P2-08-34: The network metanalysis of data from PALOMA 2, MONALEESA 2, MONARCH 3, FALCON, SWOG and FACT trials: Progression free survival (PFS) benefit from first-line endocrine-based therapies in postmenopausal women with HR+ HER2- metastatic breast cancer (MBC) according to different prognostic subgroups. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-08-34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
The three classes of Cycline Dependend Kinase (CDK) 4/6 inhibitors, Palbociclib (P), Ribociclib (R) and Abemaciclib (A), in combination with non-Steroidal Aromatase Inhibitors (nSAIs) showed improvement on Progression Free Survival (PFS) in patients with HR+/HER2- MBC compared to AIs monotherapy.
Fulvestrant (F) also showed a PFS benefit over AIs in first-line setting of endocrine naive patients (pts) which was even greater in pts whithout visceral disease.
The absence of direct comparison between F and CDK 4/6 combination therapies and their less favorable toxicity profile generated great interest in the identification of a specific subgroup of pts based on clinical and pathological factors for decision-making in the use of endocrine monotherapy.
This analysis combines data from six randomized phase III trials investigating the role of endocrine-based therapies in the first-line setting of HR+/HER2- MBC to identify clinical factors in the choice among available drugs.
Methods
A Bayesian network meta-analysis was carried out for PFS; Hazard Ratio (HR) and 95% CI were reported. Potential treatment effect modifying covariates were investigated using sub-group analysis, stratifying by age, ECOG, ethnicity, prior chemotherapy or endocrine therapy exposure, measurable disease at the time of metastasis occurrence, visceral or bone only disease, time from the initial diagnosis of breast cancer to the metastasis onset. Data analysis was performed using R Statistical Software version 3.5.0
Results
In the absence of direct comparison between CDK 4/6 inhibitors + nAIs and F endocrine-based therapies, all these therapeutic options resulted in significant PFS benefit compared to nAIs monotherapy (HR: 0.74; 95% CI 0.67-0.80). However, among the three classes of CDK 4/6 inhibitors and F a significant longer PFS was observed according to some clinical-pathological factors as followed reported: from P + nAIs in “bone only” disease (HR 0.47; CI 0.25-0.86); from A + nAis in “de novo” subgroup (HR 0.60; CI 0.37-0.97), in “Asian” population (HR 0.37; CI 0.16-0.85) and “non visceral” disease (HR 0.48 CI 0.25-0.89); from R + nAIs in “de novo” subgroup (HR 0.55; CI 0.32-0.95) and in “visceral” disease (HR 0.66 CI 0.45-0.96); from all the three combination strategies (A, P and R) in “prior endocrine” exposure subgroup (HR 0.47 CI 0.25-0.87; HR 0.60 CI 0.45-0.80; HR 0.64 CI 0.41-1.0, respectively). Even though no significant PFS benefit was observed in the remaining subgroups, combined CDK 4/6 strategies appeared more effective than F according to relative HR.
Conclusions
CDK 4/6 inhibitors endocrine-based therapies as first-line treatment for postmenopausal women with HR+/HER2- MBC showed PFS improvement, regardless of prognostic subgroup and additionally advantage was emerged by indirect comparison with F. Further direct comparative studies are needed to explore greater benefits from different therapeutic options.
Citation Format: Rossi V, Giannarelli D, Berchialla P, Montemurro F, Ferretti G, Nistico' C, Vigna L, Cognetti F, Fabi A. The network metanalysis of data from PALOMA 2, MONALEESA 2, MONARCH 3, FALCON, SWOG and FACT trials: Progression free survival (PFS) benefit from first-line endocrine-based therapies in postmenopausal women with HR+ HER2- metastatic breast cancer (MBC) according to different prognostic subgroups [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-08-34.
Collapse
Affiliation(s)
- V Rossi
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - D Giannarelli
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - P Berchialla
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - F Montemurro
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - G Ferretti
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - C Nistico'
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - L Vigna
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - F Cognetti
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| | - A Fabi
- Breast Tumour Unit, S.Camillo-Forlanini Hospital of Rome, Rome, Italy; Istituto Regina Elena of Rome, Rome, Italy; University of Turin, Turin, Italy; Investigative Clinical Oncology (INCO)-Fondazione del Piemonte per l'Oncologia, Candiolo, Turin, Italy
| |
Collapse
|
48
|
Fabi A, Giannarelli D, Botticelli A, Scagnoli S, Pellegrino A, Fabbri A, Corsi D, Magri V, Pizzuti L, Paris I, Bruni V, Pace R, Lanzetta G, Stani S, Moscetti L, Marchetti P, Piesco G, Cognetti F, Rossi V. Abstract P4-13-07: SEQUERPLUS: A multicenter real practice observational study investigating the endocrine-based (E) therapies sequential approach in hormonal receptor positive (HR+) HER2 negative (-) metastatic breast cancer (MBC). Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-13-07] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Despite the sequential E therapy is recognized as the preferred approach for HR+/HER2- MBC, no data from clinical trials support the choice between the different sequential strategies.
Methods: In this retrospective study descriptive statistics are reported using the median (Interquartile range, IQR) or frequency. Progression Free Survival (PFS) curves were estimated with the Kaplan-Meier method and compared with the log-rank test. Analysis were performed by SPSS version 21.0 (SPSS Inc., Chicago, IL).
Results: From January 2006 to December 2017, 240 patients (pts) with HR+/HER2- MBC receiving at least two consecutive E therapies as first approach were selected from 12 italian cancer centers. The median age at the time of metastasis onset was 63.5 (IQR: 55-72.5) years; 184 (76.7%) pts were in menopausal status; 38 (16%) had de novo stage IV disease and the remaining 202 (84%) had recurrent BC with a median time of 78 months (5-396 months). At the beginning of MBC diagnosis, 148 (62%) pts had a single site of distant disease, 108 (45%) of whom had bone only disease and 45 (18.8%) presented visceral involvement too. The aromatase inhibitor (AI) was chosen as I-line therapy in 146 (60.9%) pts, followed by Fulvestrant (F) in 62 (25.8%) pts; the alternative I-line options were everolimus-exemestane (Eve-Exe), tamoxifene (T), Palbociclib (P)+AI and F+AI in 13 (5.4%), 14 (5.8%), 1 (0.4%) and 4 (1.7%) pts, respectively. The most favourite II-line option resulted F for 111 (46.2%) pts while the Eve-Exe combination was chosen in 70 (29.2%) pts, AI in 30 (12.5%) pts; T, AI+F, P+F and antiprogestincwere administered in 4 (1.7%), 4 (1.7%), 19 (7.9%) and 2 (0.8%) pts, respectively. For I and II-line, the AI followed by F (40%) and F followed by Eve-Exe (18%) were the most common sequential therapeutic approaches; the several alternative options were scanty used (in less than 10%). The median Progression-Free Survival (PFS) from first and second-line E therapies resulted 15.7 (95% CI 13.3-18.1) and 10.3 months (95% CI 8.7-11.9), respectively. Among 194 pts with disease progression after second-line E therapy, 87 (44.8%) received further E therapies with a median PFS 9.4 months (95% CI 7.9-10.9). The remaining 70 (29.2%) pts was treated with palliative chemotherapy. Interestingly, the median Overall Survival (OS) was even longer for pts receiving more lines of E therapies compared to the group with earlier introduction of chemotherapy (204.3 vs 92.8; p=0.007).
Finally, in the subgroup analyses a longer PFS benefit was observed in pts with disease recurrence over 12 months from initial diagnosis (38.1 vs 30.3 months p=0.04) and limited sites of disease involvement at the time of MBC diagnosis (37.6 vs 28.3 months, p=0.03)
Conclusions: The sequential use in first and second-line setting of E therapies for HR+/HER2- MBC improves median PFS up to 32.3 months. According to real practice experience the optimal sequences could be AIs followed by F and F followed by Eve-Exe. A role for these compounds should be redefined in the light of recently introduction of CDK 4/6 inhibitors in combination with AIs or F for the first or later lines.
Citation Format: Fabi A, Giannarelli D, Botticelli A, Scagnoli S, Pellegrino A, Fabbri A, Corsi D, Magri V, Pizzuti L, Paris I, Bruni V, Pace R, Lanzetta G, Stani S, Moscetti L, Marchetti P, Piesco G, Cognetti F, Rossi V. SEQUERPLUS: A multicenter real practice observational study investigating the endocrine-based (E) therapies sequential approach in hormonal receptor positive (HR+) HER2 negative (-) metastatic breast cancer (MBC) [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-13-07.
Collapse
Affiliation(s)
- A Fabi
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - D Giannarelli
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - A Botticelli
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - S Scagnoli
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - A Pellegrino
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - A Fabbri
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - D Corsi
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - V Magri
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - L Pizzuti
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - I Paris
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - V Bruni
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - R Pace
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - G Lanzetta
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - S Stani
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - L Moscetti
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - P Marchetti
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - G Piesco
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - F Cognetti
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| | - V Rossi
- Istituto Regina Elena-IFO, Rome, Italy; S.Andrea Hospital, Rome, Italy; Policlinico Umberto I Hospital, Rome, Italy; San Pietro Hospital, Rome, Italy; Belcolle Hospital, Viterbo, VT, Italy; Fatebenefratelli Hospital, Rome, Italy; Policlinico Universitario A. Gemelli, Rome, Italy; Policlinico Campus Biomedico, Rome, Italy; San Camillo de Lellis, Rieti, Italy; Istituto Neurotraumatologico Italiano, Rome, Italy; Santo Spirito Hospital, Rome, Italy; Azienda Universitaria Ospedaliera of Modena, Modena, Italy; Breast Unit, S.Camillo-Forlanini Hospital, Rome, Italy
| |
Collapse
|
49
|
Lombardi N, Sorrentino D, Rossi V, Rampinelli G, Carrassi A, Sardella A. Fumo e parodontologia. Dental Cadmos 2019. [DOI: 10.19256/d.cadmos.02.2019.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
50
|
Rossi V, Giannarelli D, Berchialla P, Nisticò C, Ferretti G, Gasparro S, Malaguti P, Russillo M, Catania G, Vigna L, Mancusi R, Cognetti F, Fabi A. Progression free survival (PFS) benefit from first line endocrine based therapies in postmenopausal women with HR+ HER2- metastatic breast cancer (MBC) according to different prognostic subgroups: A combined analysis of data from PALOMA 2, MONALEESA 2, MONARCH 3, FALCON, SWOG and FACT trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy272.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|